ZA200500886B - "1,2,4" Oxadiazoles as modulators of metabotropic glutamate receptor-5 - Google Patents
"1,2,4" Oxadiazoles as modulators of metabotropic glutamate receptor-5 Download PDFInfo
- Publication number
- ZA200500886B ZA200500886B ZA200500886A ZA200500886A ZA200500886B ZA 200500886 B ZA200500886 B ZA 200500886B ZA 200500886 A ZA200500886 A ZA 200500886A ZA 200500886 A ZA200500886 A ZA 200500886A ZA 200500886 B ZA200500886 B ZA 200500886B
- Authority
- ZA
- South Africa
- Prior art keywords
- triazol
- phenyl
- methyl
- chloro
- ylsulfanylmethyl
- Prior art date
Links
- 108010065028 Metabotropic Glutamate 5 Receptor Proteins 0.000 title claims description 4
- 102100038357 Metabotropic glutamate receptor 5 Human genes 0.000 title description 2
- 150000004866 oxadiazoles Chemical class 0.000 title 1
- -1 Cy.¢alkylcyano Chemical group 0.000 claims description 151
- 229910052799 carbon Inorganic materials 0.000 claims description 72
- 229910052757 nitrogen Inorganic materials 0.000 claims description 71
- 150000001875 compounds Chemical class 0.000 claims description 70
- 125000000217 alkyl group Chemical group 0.000 claims description 65
- 229910052760 oxygen Inorganic materials 0.000 claims description 60
- 229910052717 sulfur Inorganic materials 0.000 claims description 52
- 125000004429 atom Chemical group 0.000 claims description 49
- 229910052739 hydrogen Inorganic materials 0.000 claims description 46
- 239000001257 hydrogen Substances 0.000 claims description 46
- 125000005843 halogen group Chemical group 0.000 claims description 38
- 150000002431 hydrogen Chemical class 0.000 claims description 38
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 30
- 102000016193 Metabotropic glutamate receptors Human genes 0.000 claims description 28
- 108010010914 Metabotropic glutamate receptors Proteins 0.000 claims description 28
- 102000005962 receptors Human genes 0.000 claims description 22
- 108020003175 receptors Proteins 0.000 claims description 22
- 125000003342 alkenyl group Chemical group 0.000 claims description 17
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 16
- 230000004913 activation Effects 0.000 claims description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 14
- 208000035475 disorder Diseases 0.000 claims description 14
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 14
- 208000002193 Pain Diseases 0.000 claims description 12
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 12
- 230000001404 mediated effect Effects 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims description 9
- 125000000304 alkynyl group Chemical group 0.000 claims description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- 125000002541 furyl group Chemical group 0.000 claims description 8
- 125000002883 imidazolyl group Chemical group 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 125000002098 pyridazinyl group Chemical group 0.000 claims description 8
- 125000005494 pyridonyl group Chemical group 0.000 claims description 8
- 125000004076 pyridyl group Chemical group 0.000 claims description 8
- 125000001113 thiadiazolyl group Chemical group 0.000 claims description 8
- 125000000335 thiazolyl group Chemical group 0.000 claims description 8
- 229930192474 thiophene Natural products 0.000 claims description 8
- 125000001425 triazolyl group Chemical group 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- 125000005872 benzooxazolyl group Chemical group 0.000 claims description 6
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 6
- 125000005945 imidazopyridyl group Chemical group 0.000 claims description 6
- 238000001783 near-resonance Rayleigh scattering spectroscopy Methods 0.000 claims description 6
- 125000006574 non-aromatic ring group Chemical group 0.000 claims description 6
- 125000001715 oxadiazolyl group Chemical group 0.000 claims description 6
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims description 6
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 6
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 6
- 208000000094 Chronic Pain Diseases 0.000 claims description 5
- 208000012902 Nervous system disease Diseases 0.000 claims description 5
- 208000025966 Neurological disease Diseases 0.000 claims description 5
- 208000005298 acute pain Diseases 0.000 claims description 5
- 125000004043 oxo group Chemical group O=* 0.000 claims description 5
- 208000020016 psychiatric disease Diseases 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- 125000005213 alkyl heteroaryl group Chemical group 0.000 claims description 4
- 230000001684 chronic effect Effects 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- YOXQYPMPVOTYNO-UHFFFAOYSA-N 2-[5-(4-bromophenyl)furan-2-yl]-5-[2-[5-[5-(4-bromophenyl)furan-2-yl]-1,3,4-oxadiazol-2-yl]ethyl]-1,3,4-oxadiazole Chemical compound C1=CC(Br)=CC=C1C1=CC=C(C=2OC(CCC=3OC(=NN=3)C=3OC(=CC=3)C=3C=CC(Br)=CC=3)=NN=2)O1 YOXQYPMPVOTYNO-UHFFFAOYSA-N 0.000 claims description 2
- OCOWVEJKROOBDS-UHFFFAOYSA-N 5-[(4-methyl-1,2,4-triazol-3-yl)sulfanylmethyl]-3-thiophen-3-yl-1,2,4-oxadiazole Chemical compound CN1C=NN=C1SCC1=NC(C2=CSC=C2)=NO1 OCOWVEJKROOBDS-UHFFFAOYSA-N 0.000 claims description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 222
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 claims 125
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims 33
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 28
- 230000002265 prevention Effects 0.000 claims 16
- BBVIDBNAYOIXOE-UHFFFAOYSA-N 1,2,4-oxadiazole Chemical compound C=1N=CON=1 BBVIDBNAYOIXOE-UHFFFAOYSA-N 0.000 claims 12
- BSKHPKMHTQYZBB-UHFFFAOYSA-N alpha-methylpyridine Natural products CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 claims 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 5
- 125000002877 alkyl aryl group Chemical group 0.000 claims 5
- ZNABSHLRJQDSCG-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[2-(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)propyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(C2CC2)C=1C(C)CC(ON=1)=NC=1C1=CC=CC(Cl)=C1 ZNABSHLRJQDSCG-UHFFFAOYSA-N 0.000 claims 4
- KXKVLQRXCPHEJC-UHFFFAOYSA-N methyl acetate Chemical compound COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims 4
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 claims 4
- 150000003852 triazoles Chemical class 0.000 claims 4
- HBFYWPRDLRYEPE-UHFFFAOYSA-N 2-[2-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]propyl]-5-pyridin-4-yl-1,3,4-oxadiazole Chemical compound N=1C(C=2C=C(Cl)C=CC=2)=NOC=1C(C)CC(O1)=NN=C1C1=CC=NC=C1 HBFYWPRDLRYEPE-UHFFFAOYSA-N 0.000 claims 3
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 claims 3
- OUSRSXCQBDMDGQ-UHFFFAOYSA-N (2-chlorophenyl)-[5-[[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]methylsulfanyl]-4-(2-methylpropyl)-1,2,4-triazol-3-yl]methanol Chemical compound N=1N=C(C(O)C=2C(=CC=CC=2)Cl)N(CC(C)C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 OUSRSXCQBDMDGQ-UHFFFAOYSA-N 0.000 claims 2
- NTSVMXNABGFNSI-UHFFFAOYSA-N 2-(3-chlorophenyl)-4-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3-oxazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1SCC(N=1)=COC=1C1=CC=CC(Cl)=C1 NTSVMXNABGFNSI-UHFFFAOYSA-N 0.000 claims 2
- WMRWZYRJDGFQOS-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SCC(O1)=NN=C1C1=CC=CC(Cl)=C1 WMRWZYRJDGFQOS-UHFFFAOYSA-N 0.000 claims 2
- BXJXMGITDPAWOO-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[1-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SC(C)C(O1)=NN=C1C1=CC=CC(Cl)=C1 BXJXMGITDPAWOO-UHFFFAOYSA-N 0.000 claims 2
- HTKNGHQKKORTCR-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[2-[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]ethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1CCC(O1)=NN=C1C1=CC=CC(Cl)=C1 HTKNGHQKKORTCR-UHFFFAOYSA-N 0.000 claims 2
- YZBRMLUGMHIBRW-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[2-[5-(furan-2-yl)-4-methyl-1,2,4-triazol-3-yl]ethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(C)C=1CCC(O1)=NN=C1C1=CC=CC(Cl)=C1 YZBRMLUGMHIBRW-UHFFFAOYSA-N 0.000 claims 2
- KZURXYAMJYZOBO-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[[4-cyclopropyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,3,4-oxadiazole Chemical compound ClC1=CC=CC(C=2OC(CSC=3N(C(C=4OC=CC=4)=NN=3)C3CC3)=NN=2)=C1 KZURXYAMJYZOBO-UHFFFAOYSA-N 0.000 claims 2
- ULWHKXNKMVUFEE-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[[4-ethyl-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=CC(OC)=CC=2)N(CC)C=1SCC(O1)=NN=C1C1=CC=CC(Cl)=C1 ULWHKXNKMVUFEE-UHFFFAOYSA-N 0.000 claims 2
- KUUCPQZYDHJKPG-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[[4-methyl-5-(1,3-thiazol-4-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2N=CSC=2)N(C)C=1SCC(O1)=NN=C1C1=CC=CC(Cl)=C1 KUUCPQZYDHJKPG-UHFFFAOYSA-N 0.000 claims 2
- DLAVPWKEQZNLKI-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[[5-(4-methoxyphenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,3,4-oxadiazole Chemical compound C1=CC(OC)=CC=C1C(N1C)=NN=C1SCC1=NN=C(C=2C=C(Cl)C=CC=2)O1 DLAVPWKEQZNLKI-UHFFFAOYSA-N 0.000 claims 2
- QKXRKEITNCCVFO-UHFFFAOYSA-N 2-(5-chloro-2-fluorophenyl)-5-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SCC(O1)=NN=C1C1=CC(Cl)=CC=C1F QKXRKEITNCCVFO-UHFFFAOYSA-N 0.000 claims 2
- YXFMOEVKXZGLNU-UHFFFAOYSA-N 2-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(2-methylpyridin-4-yl)-1,3,4-oxadiazole Chemical compound C1=NC(C)=CC(C=2OC(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)=NN=2)=C1 YXFMOEVKXZGLNU-UHFFFAOYSA-N 0.000 claims 2
- DMLDGIMNZIUYFE-UHFFFAOYSA-N 2-[1-[[4-ethyl-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-5-(2-methylpyridin-4-yl)-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=CC(OC)=CC=2)N(CC)C=1SC(C)C(O1)=NN=C1C1=CC=NC(C)=C1 DMLDGIMNZIUYFE-UHFFFAOYSA-N 0.000 claims 2
- MLGZSMLWWKJDRS-UHFFFAOYSA-N 2-[1-[[5-(furan-2-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]ethyl]-5-(2-methylpyridin-4-yl)-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=C(C)N=CC=2)OC=1C(C)SC(N1C)=NN=C1C1=CC=CO1 MLGZSMLWWKJDRS-UHFFFAOYSA-N 0.000 claims 2
- CMGFJVMEUMGONW-UHFFFAOYSA-N 2-[3-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazol-5-yl]-4-methylphenol Chemical compound CC1=CC=C(O)C(C=2ON=C(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)N=2)=C1 CMGFJVMEUMGONW-UHFFFAOYSA-N 0.000 claims 2
- ILBBYJLQTQJUQN-UHFFFAOYSA-N 2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(3-methylphenyl)-1,3,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(O1)=NN=C1C1=CC=CC(C)=C1 ILBBYJLQTQJUQN-UHFFFAOYSA-N 0.000 claims 2
- GSFNQBFZFXUTBN-UHFFFAOYSA-N 2-chlorothiophene Chemical compound ClC1=CC=CS1 GSFNQBFZFXUTBN-UHFFFAOYSA-N 0.000 claims 2
- OKEHURCMYKPVFW-UHFFFAOYSA-N 2-methoxythiophene Chemical compound COC1=CC=CS1 OKEHURCMYKPVFW-UHFFFAOYSA-N 0.000 claims 2
- XQQBUAPQHNYYRS-UHFFFAOYSA-N 2-methylthiophene Chemical compound CC1=CC=CS1 XQQBUAPQHNYYRS-UHFFFAOYSA-N 0.000 claims 2
- OQPNEGFPIPPLMT-UHFFFAOYSA-N 3-(1h-benzimidazol-2-ylsulfanylmethyl)-5-(3-methoxyphenyl)-1,2,4-oxadiazole Chemical compound COC1=CC=CC(C=2ON=C(CSC=3NC4=CC=CC=C4N=3)N=2)=C1 OQPNEGFPIPPLMT-UHFFFAOYSA-N 0.000 claims 2
- XFOZJPDZNJSRGN-UHFFFAOYSA-N 3-(1h-benzimidazol-2-ylsulfanylmethyl)-5-(3-methylsulfanylphenyl)-1,2,4-oxadiazole Chemical compound CSC1=CC=CC(C=2ON=C(CSC=3NC4=CC=CC=C4N=3)N=2)=C1 XFOZJPDZNJSRGN-UHFFFAOYSA-N 0.000 claims 2
- GKCXMQKTLIXVNI-UHFFFAOYSA-N 3-(1h-imidazo[4,5-b]pyridin-2-ylsulfanylmethyl)-5-(3-methoxyphenyl)-1,2,4-oxadiazole Chemical compound COC1=CC=CC(C=2ON=C(CSC=3NC4=CC=CN=C4N=3)N=2)=C1 GKCXMQKTLIXVNI-UHFFFAOYSA-N 0.000 claims 2
- ALLSGPSLURSREQ-UHFFFAOYSA-N 3-(2,5-difluorophenyl)-5-[[5-(furan-2-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(C)C=1SCC(ON=1)=NC=1C1=CC(F)=CC=C1F ALLSGPSLURSREQ-UHFFFAOYSA-N 0.000 claims 2
- GZINSWYCDFVOLK-UHFFFAOYSA-N 3-(2-fluoro-5-methylphenyl)-5-[(4-methyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=C(F)C(C=2N=C(CSC=3N(C(C=4C=NC=CC=4)=NN=3)C)ON=2)=C1 GZINSWYCDFVOLK-UHFFFAOYSA-N 0.000 claims 2
- UAMZXDHZDGFYSZ-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[(4-methyl-5-pyrimidin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2N=CN=CC=2)N(C)C=1SCC(ON=1)=NC=1C1=CC=CC(Cl)=C1 UAMZXDHZDGFYSZ-UHFFFAOYSA-N 0.000 claims 2
- DGMHSHCJPYYMBR-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[1-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1C(C=2C=C(Cl)C=CC=2)=NOC=1C(C)SC(N1C)=NN=C1C1=CC=CS1 DGMHSHCJPYYMBR-UHFFFAOYSA-N 0.000 claims 2
- RIPPGLFDJGGJAF-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[[4-ethyl-5-(2-methoxyethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CCN1C(CCOC)=NN=C1SCC1=NC(C=2C=C(Cl)C=CC=2)=NO1 RIPPGLFDJGGJAF-UHFFFAOYSA-N 0.000 claims 2
- MNRNEARDLAQMNG-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(ON=1)=NC=1C1=CC=CC(Cl)=C1 MNRNEARDLAQMNG-UHFFFAOYSA-N 0.000 claims 2
- PHVCRIYWGCGBJL-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[[4-ethyl-5-(methoxymethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CCN1C(COC)=NN=C1SCC1=NC(C=2C=C(Cl)C=CC=2)=NO1 PHVCRIYWGCGBJL-UHFFFAOYSA-N 0.000 claims 2
- POOIAPQDQJUGKU-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[[5-(furan-3-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C2=COC=C2)N(C)C=1SCC(ON=1)=NC=1C1=CC=CC(Cl)=C1 POOIAPQDQJUGKU-UHFFFAOYSA-N 0.000 claims 2
- BSSCWAKAOAJZNW-UHFFFAOYSA-N 3-(3-fluorophenyl)-5-[(4-methyl-5-thiophen-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C2=CSC=C2)N(C)C=1SCC(ON=1)=NC=1C1=CC=CC(F)=C1 BSSCWAKAOAJZNW-UHFFFAOYSA-N 0.000 claims 2
- MRLGYRLNPLLMMI-UHFFFAOYSA-N 3-(3-methoxyphenyl)-5-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound COC1=CC=CC(C=2N=C(CSC=3N(C(C=4SC=CC=4)=NN=3)C)ON=2)=C1 MRLGYRLNPLLMMI-UHFFFAOYSA-N 0.000 claims 2
- JXDVYCPGGPJJHX-UHFFFAOYSA-N 3-(5-chloro-2-fluorophenyl)-5-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(ON=1)=NC=1C1=CC(Cl)=CC=C1F JXDVYCPGGPJJHX-UHFFFAOYSA-N 0.000 claims 2
- JDAVULZPYAGASP-UHFFFAOYSA-N 3-[(4-ethyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(3-methylphenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=NC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(C)=C1 JDAVULZPYAGASP-UHFFFAOYSA-N 0.000 claims 2
- CNXAYRIHLXOIBT-UHFFFAOYSA-N 3-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(2-fluoro-5-methylphenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(C)=CC=C1F CNXAYRIHLXOIBT-UHFFFAOYSA-N 0.000 claims 2
- COHTWMLCHHQHSA-UHFFFAOYSA-N 3-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(3-methylphenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(C)=C1 COHTWMLCHHQHSA-UHFFFAOYSA-N 0.000 claims 2
- SEPQUPXZLIWDMG-UHFFFAOYSA-N 3-[(4-ethyl-5-thiophen-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(3-methylphenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C2=CSC=C2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(C)=C1 SEPQUPXZLIWDMG-UHFFFAOYSA-N 0.000 claims 2
- ZEMWXQPZCKUZRM-UHFFFAOYSA-N 3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(1,3-thiazol-4-yl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CSC=N1 ZEMWXQPZCKUZRM-UHFFFAOYSA-N 0.000 claims 2
- VUDUCRTZCYOQHS-UHFFFAOYSA-N 3-[(4-methyl-5-thiophen-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-thiophen-2-yl-1,2,4-oxadiazole Chemical compound N=1N=C(C2=CSC=C2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CS1 VUDUCRTZCYOQHS-UHFFFAOYSA-N 0.000 claims 2
- MLNNQOPIYMHFMZ-UHFFFAOYSA-N 3-[1-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-5-(3-methoxyphenyl)-1,2,4-oxadiazole Chemical compound COC1=CC=CC(C=2ON=C(N=2)C(C)SC=2N(C(C=3C=CN=CC=3)=NN=2)C2CC2)=C1 MLNNQOPIYMHFMZ-UHFFFAOYSA-N 0.000 claims 2
- GTVRFBCWAHCPMG-UHFFFAOYSA-N 3-[1-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-5-(2-fluoro-5-methylphenyl)-1,2-oxazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SC(C)C(=NO1)C=C1C1=CC(C)=CC=C1F GTVRFBCWAHCPMG-UHFFFAOYSA-N 0.000 claims 2
- WMGYQRPMXDUCCX-UHFFFAOYSA-N 3-[1-[5-(3-chlorophenyl)-1,3,4-oxadiazol-2-yl]ethylsulfanyl]-5-pyridin-4-yl-1,2,4-triazol-4-amine Chemical compound N=1N=C(C=2C=C(Cl)C=CC=2)OC=1C(C)SC(N1N)=NN=C1C1=CC=NC=C1 WMGYQRPMXDUCCX-UHFFFAOYSA-N 0.000 claims 2
- YWOWWCALYZWZEP-UHFFFAOYSA-N 3-[3-[1-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazol-5-yl]benzonitrile Chemical compound N=1OC(C=2C=C(C=CC=2)C#N)=NC=1C(C)SC(N1C)=NN=C1C1=CC=NC=C1 YWOWWCALYZWZEP-UHFFFAOYSA-N 0.000 claims 2
- MNLLLRRKPYVSAH-UHFFFAOYSA-N 3-[3-[[5-(3-chlorothiophen-2-yl)-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazol-5-yl]benzonitrile Chemical compound N=1N=C(C2=C(C=CS2)Cl)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(C#N)=C1 MNLLLRRKPYVSAH-UHFFFAOYSA-N 0.000 claims 2
- MNUUTELSCJACCG-UHFFFAOYSA-N 3-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(2-fluoro-5-methylphenyl)-1,2-oxazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(=NO1)C=C1C1=CC(C)=CC=C1F MNUUTELSCJACCG-UHFFFAOYSA-N 0.000 claims 2
- LUMNYCRVFWVRIY-UHFFFAOYSA-N 3-[[4-ethyl-5-(oxolan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(3-methylphenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C2OCCC2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(C)=C1 LUMNYCRVFWVRIY-UHFFFAOYSA-N 0.000 claims 2
- PJNUFBUGGIPPPH-UHFFFAOYSA-N 3-[[4-ethyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-thiophen-3-yl-1,2,4-oxadiazole Chemical compound N1=C(C(F)(F)F)N(CC)C(SCC=2N=C(ON=2)C2=CSC=C2)=N1 PJNUFBUGGIPPPH-UHFFFAOYSA-N 0.000 claims 2
- KJFXTEQFPJWRER-UHFFFAOYSA-N 3-[[5-(2,6-dichloropyridin-4-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(3-methylphenyl)-1,2,4-oxadiazole Chemical compound CC1=CC=CC(C=2ON=C(CSC=3N(C(C=4C=C(Cl)N=C(Cl)C=4)=NN=3)C)N=2)=C1 KJFXTEQFPJWRER-UHFFFAOYSA-N 0.000 claims 2
- AJRGDQWFWJDYDP-UHFFFAOYSA-N 3-chloro-1,2-oxazole Chemical compound ClC=1C=CON=1 AJRGDQWFWJDYDP-UHFFFAOYSA-N 0.000 claims 2
- CUMCMYMKECWGHO-UHFFFAOYSA-N 3-methyl-1,2-oxazole Chemical compound CC=1C=CON=1 CUMCMYMKECWGHO-UHFFFAOYSA-N 0.000 claims 2
- LTVREEOZCOPBRN-UHFFFAOYSA-N 4-[[5-[[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]methylsulfanyl]-4-ethyl-1,2,4-triazol-3-yl]methoxy]phenol Chemical compound N=1N=C(SCC=2N=C(ON=2)C=2C=C(Cl)C=CC=2)N(CC)C=1COC1=CC=C(O)C=C1 LTVREEOZCOPBRN-UHFFFAOYSA-N 0.000 claims 2
- WMXVMYBJSRMVTK-UHFFFAOYSA-N 4-benzyl-2-[4-methyl-5-[[5-(3-methylphenyl)-1,2,4-oxadiazol-3-yl]methylsulfanyl]-1,2,4-triazol-3-yl]morpholine Chemical compound CC1=CC=CC(C=2ON=C(CSC=3N(C(C4OCCN(CC=5C=CC=CC=5)C4)=NN=3)C)N=2)=C1 WMXVMYBJSRMVTK-UHFFFAOYSA-N 0.000 claims 2
- DWQMVWMNLWYLCE-UHFFFAOYSA-N 5-(2,5-dichlorophenyl)-3-[(4-ethyl-5-thiophen-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C2=CSC=C2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(Cl)=CC=C1Cl DWQMVWMNLWYLCE-UHFFFAOYSA-N 0.000 claims 2
- GRNDAPWRNZWJDN-UHFFFAOYSA-N 5-(2,5-difluorophenyl)-3-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(F)=CC=C1F GRNDAPWRNZWJDN-UHFFFAOYSA-N 0.000 claims 2
- AFPGSICNGIINDI-UHFFFAOYSA-N 5-(2,5-difluorophenyl)-3-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(F)=CC=C1F AFPGSICNGIINDI-UHFFFAOYSA-N 0.000 claims 2
- UCHDIIADCUAHRS-UHFFFAOYSA-N 5-(2,5-difluorophenyl)-3-[(4-ethyl-5-thiophen-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C2=CSC=C2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(F)=CC=C1F UCHDIIADCUAHRS-UHFFFAOYSA-N 0.000 claims 2
- OAUQQTCROZXFPF-UHFFFAOYSA-N 5-(2,5-difluorophenyl)-3-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(F)=CC=C1F OAUQQTCROZXFPF-UHFFFAOYSA-N 0.000 claims 2
- BVNOOFHAASAPDA-UHFFFAOYSA-N 5-(2,5-dimethylphenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=C(C)C(C=2ON=C(CSC=3N(C(C=4SC=CC=4)=NN=3)C)N=2)=C1 BVNOOFHAASAPDA-UHFFFAOYSA-N 0.000 claims 2
- QKZIOSZGVGFRRM-UHFFFAOYSA-N 5-(2-chlorophenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC=C1Cl QKZIOSZGVGFRRM-UHFFFAOYSA-N 0.000 claims 2
- FMQXAKIGOZZDAL-UHFFFAOYSA-N 5-(2-chloropyridin-4-yl)-3-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound C1=NC(Cl)=CC(C=2ON=C(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)N=2)=C1 FMQXAKIGOZZDAL-UHFFFAOYSA-N 0.000 claims 2
- PJXDKKYWNKTKDH-UHFFFAOYSA-N 5-(2-fluoro-5-methylphenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=C(F)C(C=2ON=C(CSC=3N(C(C=4SC=CC=4)=NN=3)C)N=2)=C1 PJXDKKYWNKTKDH-UHFFFAOYSA-N 0.000 claims 2
- WCPVASMMXJWICK-UHFFFAOYSA-N 5-(2-fluorophenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC=C1F WCPVASMMXJWICK-UHFFFAOYSA-N 0.000 claims 2
- PMVPMCSWEIASMZ-UHFFFAOYSA-N 5-(2-methoxyphenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound COC1=CC=CC=C1C1=NC(CSC=2N(C(C=3SC=CC=3)=NN=2)C)=NO1 PMVPMCSWEIASMZ-UHFFFAOYSA-N 0.000 claims 2
- QDECZUYNVXPYBJ-UHFFFAOYSA-N 5-(2-methylpyridin-4-yl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound C1=NC(C)=CC(C=2ON=C(CSC=3N(C(C=4SC=CC=4)=NN=3)C)N=2)=C1 QDECZUYNVXPYBJ-UHFFFAOYSA-N 0.000 claims 2
- VNDDCQMEFUVUGP-UHFFFAOYSA-N 5-(3-chlorophenyl)-2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3-oxazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(O1)=NC=C1C1=CC=CC(Cl)=C1 VNDDCQMEFUVUGP-UHFFFAOYSA-N 0.000 claims 2
- DLRVNGFMSUOVDF-UHFFFAOYSA-N 5-(3-chlorophenyl)-2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,3-oxazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(O1)=NC=C1C1=CC=CC(Cl)=C1 DLRVNGFMSUOVDF-UHFFFAOYSA-N 0.000 claims 2
- RNNGGRAGEVFIFX-UHFFFAOYSA-N 5-(3-chlorophenyl)-2-[[4-ethyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,3-oxazole Chemical compound N1=C(C(F)(F)F)N(CC)C(SCC=2OC(=CN=2)C=2C=C(Cl)C=CC=2)=N1 RNNGGRAGEVFIFX-UHFFFAOYSA-N 0.000 claims 2
- PISVVOOSADIMGE-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 PISVVOOSADIMGE-UHFFFAOYSA-N 0.000 claims 2
- UUALMNKSIQRDJF-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(4-methyl-5-pyrimidin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2N=CN=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 UUALMNKSIQRDJF-UHFFFAOYSA-N 0.000 claims 2
- LHAVWNNARPYZLN-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(4-propyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CCC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 LHAVWNNARPYZLN-UHFFFAOYSA-N 0.000 claims 2
- MPAJKCBBDDZNIY-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-1,2-oxazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SC(C)C(=NO1)C=C1C1=CC=CC(Cl)=C1 MPAJKCBBDDZNIY-UHFFFAOYSA-N 0.000 claims 2
- STTVHILXNWIIQL-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[2-(furan-2-yl)-3-methylimidazol-4-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound C=1N=C(C=2OC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 STTVHILXNWIIQL-UHFFFAOYSA-N 0.000 claims 2
- JCMVYEFOOAUPHL-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-ethyl-5-(4-fluorophenyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CC(F)=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 JCMVYEFOOAUPHL-UHFFFAOYSA-N 0.000 claims 2
- NGCOSTLGFWFGCH-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-ethyl-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2-oxazole Chemical compound N=1N=C(C=2C=CC(OC)=CC=2)N(CC)C=1SCC(=NO1)C=C1C1=CC=CC(Cl)=C1 NGCOSTLGFWFGCH-UHFFFAOYSA-N 0.000 claims 2
- GRGQWHCBZQXYOI-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-ethyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2-oxazole Chemical compound N1=C(C(F)(F)F)N(CC)C(SCC2=NOC(=C2)C=2C=C(Cl)C=CC=2)=N1 GRGQWHCBZQXYOI-UHFFFAOYSA-N 0.000 claims 2
- PPGCELFTJCIQKO-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-ethyl-5-[(4-methoxyphenoxy)methyl]-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(SCC=2N=C(ON=2)C=2C=C(Cl)C=CC=2)N(CC)C=1COC1=CC=C(OC)C=C1 PPGCELFTJCIQKO-UHFFFAOYSA-N 0.000 claims 2
- PCYFPLUJHRZXHP-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-methyl-5-(1-oxidopyridin-1-ium-4-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=C[N+]([O-])=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 PCYFPLUJHRZXHP-UHFFFAOYSA-N 0.000 claims 2
- SQLWTJQDLLUPMR-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[5-(2-fluorophenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C(=CC=CC=2)F)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 SQLWTJQDLLUPMR-UHFFFAOYSA-N 0.000 claims 2
- NYBOLTGXTOYXDM-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[5-(3-fluorophenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=C(F)C=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 NYBOLTGXTOYXDM-UHFFFAOYSA-N 0.000 claims 2
- KOKFKFBMUOWJSP-UHFFFAOYSA-N 5-(3-fluorophenyl)-3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(F)=C1 KOKFKFBMUOWJSP-UHFFFAOYSA-N 0.000 claims 2
- SAMSMMJVUFGISH-UHFFFAOYSA-N 5-(3-fluorophenyl)-3-[(4-methyl-5-thiophen-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C2=CSC=C2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(F)=C1 SAMSMMJVUFGISH-UHFFFAOYSA-N 0.000 claims 2
- YQORNKOGZVKMLV-UHFFFAOYSA-N 5-(3-iodophenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(I)=C1 YQORNKOGZVKMLV-UHFFFAOYSA-N 0.000 claims 2
- ATWIRKKUFPRTBY-UHFFFAOYSA-N 5-(3-methylphenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfinylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=CC(C=2ON=C(CS(=O)C=3N(C(C=4SC=CC=4)=NN=3)C)N=2)=C1 ATWIRKKUFPRTBY-UHFFFAOYSA-N 0.000 claims 2
- OQFCQRMIQQRPQU-UHFFFAOYSA-N 5-(3-methylphenyl)-3-[[4-methyl-5-(1,3-thiazol-4-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=CC(C=2ON=C(CSC=3N(C(C=4N=CSC=4)=NN=3)C)N=2)=C1 OQFCQRMIQQRPQU-UHFFFAOYSA-N 0.000 claims 2
- MKPLRZVBULASCK-UHFFFAOYSA-N 5-(3-methylphenyl)-3-[[4-methyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=CC(C=2ON=C(CSC=3N(C(=NN=3)C(F)(F)F)C)N=2)=C1 MKPLRZVBULASCK-UHFFFAOYSA-N 0.000 claims 2
- NOOSFLNXDDIFJE-UHFFFAOYSA-N 5-(4-methoxythiophen-3-yl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound COC1=CSC=C1C1=NC(CSC=2N(C(C=3SC=CC=3)=NN=2)C)=NO1 NOOSFLNXDDIFJE-UHFFFAOYSA-N 0.000 claims 2
- KFPGGZGHKKLMAE-UHFFFAOYSA-N 5-(5-bromo-2-fluorophenyl)-3-[(4-methyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=NC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC(Br)=CC=C1F KFPGGZGHKKLMAE-UHFFFAOYSA-N 0.000 claims 2
- RVUKWCXLYZKTMC-UHFFFAOYSA-N 5-(5-bromo-2-fluorophenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC(Br)=CC=C1F RVUKWCXLYZKTMC-UHFFFAOYSA-N 0.000 claims 2
- YBTREHJSDIAZGA-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2-oxazole Chemical compound FC1=CC=C(Cl)C=C1C1=CC(CSC=2N(C(C=3C=CN=CC=3)=NN=2)C2CC2)=NO1 YBTREHJSDIAZGA-UHFFFAOYSA-N 0.000 claims 2
- DLXNDJPBHJMKKT-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[(4-cyclopropyl-5-pyrimidin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound FC1=CC=C(Cl)C=C1C1=NC(CSC=2N(C(C=3N=CN=CC=3)=NN=2)C2CC2)=NO1 DLXNDJPBHJMKKT-UHFFFAOYSA-N 0.000 claims 2
- WJDDDFDGKQYEIA-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[1-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1OC(C=2C(=CC=C(Cl)C=2)F)=NC=1C(C)SC(N1C)=NN=C1C1=CC=NC=C1 WJDDDFDGKQYEIA-UHFFFAOYSA-N 0.000 claims 2
- HHFMMESDZHCQAJ-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[[4-(2-fluoroethyl)-5-thiophen-2-yl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CCF)C=1SCC(N=1)=NOC=1C1=CC(Cl)=CC=C1F HHFMMESDZHCQAJ-UHFFFAOYSA-N 0.000 claims 2
- QQRHWDAJHUONHR-UHFFFAOYSA-N 5-(5-chlorothiophen-2-yl)-3-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=C(Cl)S1 QQRHWDAJHUONHR-UHFFFAOYSA-N 0.000 claims 2
- WMDXRHAMNAJCDK-UHFFFAOYSA-N 5-(5-chlorothiophen-3-yl)-3-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CSC(Cl)=C1 WMDXRHAMNAJCDK-UHFFFAOYSA-N 0.000 claims 2
- NVBSAASFCDSIIW-UHFFFAOYSA-N 5-(5-chlorothiophen-3-yl)-3-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2-oxazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(=NO1)C=C1C1=CSC(Cl)=C1 NVBSAASFCDSIIW-UHFFFAOYSA-N 0.000 claims 2
- GGYHTHVKGJACRO-UHFFFAOYSA-N 5-[3-(difluoromethoxy)phenyl]-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(OC(F)F)=C1 GGYHTHVKGJACRO-UHFFFAOYSA-N 0.000 claims 2
- UWZGWPYARRYJEB-UHFFFAOYSA-N 5-[3-(furan-3-yl)phenyl]-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C(C=1)=CC=CC=1C=1C=COC=1 UWZGWPYARRYJEB-UHFFFAOYSA-N 0.000 claims 2
- BJRIGRMFQWMSJF-UHFFFAOYSA-N 5-[5-[1-[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]ethylsulfanyl]-4-ethyl-1,2,4-triazol-3-yl]-1H-pyridin-2-one Chemical compound N=1N=C(C=2C=NC(O)=CC=2)N(CC)C=1SC(C)C(N=1)=NOC=1C1=CC=CC(Cl)=C1 BJRIGRMFQWMSJF-UHFFFAOYSA-N 0.000 claims 2
- DJGKVBNDRBGOLC-UHFFFAOYSA-N 5-[[4-ethyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-3-(3-methoxyphenyl)-1,2,4-oxadiazole Chemical compound N1=C(C(F)(F)F)N(CC)C(SCC=2ON=C(N=2)C=2C=C(OC)C=CC=2)=N1 DJGKVBNDRBGOLC-UHFFFAOYSA-N 0.000 claims 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 102000012777 Metabotropic Glutamate 5 Receptor Human genes 0.000 claims 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 2
- QENGPZGAWFQWCZ-UHFFFAOYSA-N Methylthiophene Natural products CC=1C=CSC=1 QENGPZGAWFQWCZ-UHFFFAOYSA-N 0.000 claims 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 claims 2
- YFNONBGXNFCTMM-UHFFFAOYSA-N butoxybenzene Chemical group CCCCOC1=CC=CC=C1 YFNONBGXNFCTMM-UHFFFAOYSA-N 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- HEZQRPHEDDAJTF-UHFFFAOYSA-N chloro(phenyl)methanol Chemical compound OC(Cl)C1=CC=CC=C1 HEZQRPHEDDAJTF-UHFFFAOYSA-N 0.000 claims 2
- 125000000068 chlorophenyl group Chemical group 0.000 claims 2
- 125000006378 chloropyridyl group Chemical group 0.000 claims 2
- 125000004802 cyanophenyl group Chemical group 0.000 claims 2
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 2
- 125000004188 dichlorophenyl group Chemical group 0.000 claims 2
- 125000004212 difluorophenyl group Chemical group 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims 2
- 125000004175 fluorobenzyl group Chemical group 0.000 claims 2
- 125000003784 fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 claims 2
- 125000001207 fluorophenyl group Chemical group 0.000 claims 2
- 125000004464 hydroxyphenyl group Chemical group 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 2
- 125000006178 methyl benzyl group Chemical group 0.000 claims 2
- 125000006384 methylpyridyl group Chemical group 0.000 claims 2
- OTOIYFALVZJXKE-UHFFFAOYSA-N n,n-dimethyl-3-[3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazol-5-yl]aniline Chemical compound CN(C)C1=CC=CC(C=2ON=C(CSC=3N(C(C=4SC=CC=4)=NN=3)C)N=2)=C1 OTOIYFALVZJXKE-UHFFFAOYSA-N 0.000 claims 2
- GVNGMRDTPPFXFZ-UHFFFAOYSA-N n-[[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]methyl]-n,4-dimethyl-5-pyridin-4-yl-1,2,4-triazol-3-amine Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1N(C)CC(N=1)=NOC=1C1=CC=CC(Cl)=C1 GVNGMRDTPPFXFZ-UHFFFAOYSA-N 0.000 claims 2
- 125000006501 nitrophenyl group Chemical group 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 2
- 125000003944 tolyl group Chemical group 0.000 claims 2
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 125000001305 1,2,4-triazol-3-yl group Chemical group [H]N1N=C([*])N=C1[H] 0.000 claims 1
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 claims 1
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 claims 1
- HEACMNRMWPGIPI-UHFFFAOYSA-N 2-(2-chloropyridin-4-yl)-5-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3,4-oxadiazole Chemical compound C1=NC(Cl)=CC(C=2OC(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)=NN=2)=C1 HEACMNRMWPGIPI-UHFFFAOYSA-N 0.000 claims 1
- VBAXHHSOLYSMTK-UHFFFAOYSA-N 2-(2-chloropyridin-4-yl)-5-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(O1)=NN=C1C1=CC=NC(Cl)=C1 VBAXHHSOLYSMTK-UHFFFAOYSA-N 0.000 claims 1
- VHGWFMVDIQOLMO-UHFFFAOYSA-N 2-(2-fluoro-5-methylphenyl)-5-[1-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C(=CC=C(C)C=2)F)OC=1C(C)SC(N1C)=NN=C1C1=CC=NC=C1 VHGWFMVDIQOLMO-UHFFFAOYSA-N 0.000 claims 1
- PYGXCGRPTSPWCS-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[(3-pyridin-4-yl-6,7-dihydro-5h-[1,2,4]triazolo[4,3-a]pyrimidin-8-yl)methyl]-1,3,4-oxadiazole Chemical compound ClC1=CC=CC(C=2OC(CN3C=4N(C(=NN=4)C=4C=CN=CC=4)CCC3)=NN=2)=C1 PYGXCGRPTSPWCS-UHFFFAOYSA-N 0.000 claims 1
- FBIPQZPTASPONC-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3,4-oxadiazole Chemical compound ClC1=CC=CC(C=2OC(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)=NN=2)=C1 FBIPQZPTASPONC-UHFFFAOYSA-N 0.000 claims 1
- WOCLAVMTZUFYNA-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1SCC(O1)=NN=C1C1=CC=CC(Cl)=C1 WOCLAVMTZUFYNA-UHFFFAOYSA-N 0.000 claims 1
- KBCVRIFRAIKGPZ-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[1-(3-pyridin-4-yl-6,7-dihydro-5h-[1,2,4]triazolo[4,3-a]pyrimidin-8-yl)ethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=C(Cl)C=CC=2)OC=1C(C)N1CCCN2C1=NN=C2C1=CC=NC=C1 KBCVRIFRAIKGPZ-UHFFFAOYSA-N 0.000 claims 1
- HEWWVGWCMRENAG-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[1-(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)propan-2-yl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=C(Cl)C=CC=2)OC=1C(C)CC(N1C2CC2)=NN=C1C1=CC=NC=C1 HEWWVGWCMRENAG-UHFFFAOYSA-N 0.000 claims 1
- XGYVDPKOEIRQRW-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[1-(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)propan-2-yl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=C(Cl)C=CC=2)OC=1C(C)CC(N1C)=NN=C1C1=CC=NC=C1 XGYVDPKOEIRQRW-UHFFFAOYSA-N 0.000 claims 1
- GMWAOBFOOGYGIO-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[1-[(4-methyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=C(Cl)C=CC=2)OC=1C(C)SC(N1C)=NN=C1C1=CC=CN=C1 GMWAOBFOOGYGIO-UHFFFAOYSA-N 0.000 claims 1
- NGAWNSDTIGKJEA-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[1-[[4-(cyclopropylmethyl)-5-pyridin-4-yl-1,2,4-triazol-3-yl]sulfanyl]ethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=C(Cl)C=CC=2)OC=1C(C)SC(N1CC2CC2)=NN=C1C1=CC=NC=C1 NGAWNSDTIGKJEA-UHFFFAOYSA-N 0.000 claims 1
- PBVVTBFCKFAIBN-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[1-[[4-methyl-5-(2-methyl-1,3-thiazol-4-yl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=C(Cl)C=CC=2)OC=1C(C)SC(N1C)=NN=C1C1=CSC(C)=N1 PBVVTBFCKFAIBN-UHFFFAOYSA-N 0.000 claims 1
- HMPRNAWUOORIAA-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[1-[[4-methyl-5-(2-methylpyridin-4-yl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=C(Cl)C=CC=2)OC=1C(C)SC(N1C)=NN=C1C1=CC=NC(C)=C1 HMPRNAWUOORIAA-UHFFFAOYSA-N 0.000 claims 1
- WPEJKDSVNNGUEX-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[2-[4-cyclopropyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]ethyl]-1,3,4-oxadiazole Chemical compound ClC1=CC=CC(C=2OC(CCC=3N(C(C=4OC=CC=4)=NN=3)C3CC3)=NN=2)=C1 WPEJKDSVNNGUEX-UHFFFAOYSA-N 0.000 claims 1
- YJRMEWCVLKPBTR-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[[4-ethyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,3,4-oxadiazole Chemical compound N1=C(C(F)(F)F)N(CC)C(SCC=2OC(=NN=2)C=2C=C(Cl)C=CC=2)=N1 YJRMEWCVLKPBTR-UHFFFAOYSA-N 0.000 claims 1
- LJQPFOILFKBCSR-UHFFFAOYSA-N 2-(3-chlorophenyl)-5-[[5-(furan-2-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(C)C=1SCC(O1)=NN=C1C1=CC=CC(Cl)=C1 LJQPFOILFKBCSR-UHFFFAOYSA-N 0.000 claims 1
- IJJNQTFUAXXXCS-UHFFFAOYSA-N 2-(3-methylphenyl)-5-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3,4-oxadiazole Chemical compound CC1=CC=CC(C=2OC(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C)=NN=2)=C1 IJJNQTFUAXXXCS-UHFFFAOYSA-N 0.000 claims 1
- KSTGNASRKIUJCU-UHFFFAOYSA-N 2-(5-chloro-2-fluorophenyl)-5-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3,4-oxadiazole Chemical compound FC1=CC=C(Cl)C=C1C(O1)=NN=C1CSC(N1C2CC2)=NN=C1C1=CC=NC=C1 KSTGNASRKIUJCU-UHFFFAOYSA-N 0.000 claims 1
- UELSNOKJLLTGPU-UHFFFAOYSA-N 2-(5-chloro-2-fluorophenyl)-5-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1SCC(O1)=NN=C1C1=CC(Cl)=CC=C1F UELSNOKJLLTGPU-UHFFFAOYSA-N 0.000 claims 1
- KUMOBSCBPBTFQL-UHFFFAOYSA-N 2-(5-chloro-2-fluorophenyl)-5-[1-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C(=CC=C(Cl)C=2)F)OC=1C(C)SC(N1C2CC2)=NN=C1C1=CC=NC=C1 KUMOBSCBPBTFQL-UHFFFAOYSA-N 0.000 claims 1
- UKIPZEGXADMCFP-UHFFFAOYSA-N 2-(5-chloro-2-fluorophenyl)-5-[1-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SC(C)C(O1)=NN=C1C1=CC(Cl)=CC=C1F UKIPZEGXADMCFP-UHFFFAOYSA-N 0.000 claims 1
- BOHIAMNRXPRDQH-UHFFFAOYSA-N 2-(5-chloro-2-fluorophenyl)-5-[1-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C(=CC=C(Cl)C=2)F)OC=1C(C)SC(N1C)=NN=C1C1=CC=NC=C1 BOHIAMNRXPRDQH-UHFFFAOYSA-N 0.000 claims 1
- FXXMHIIFFKJSOE-UHFFFAOYSA-N 2-(5-chloro-2-fluorophenyl)-5-[1-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-1,3,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SC(C)C(O1)=NN=C1C1=CC(Cl)=CC=C1F FXXMHIIFFKJSOE-UHFFFAOYSA-N 0.000 claims 1
- IDNLAZRWSIDOAH-UHFFFAOYSA-N 2-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(2-fluoro-5-methylphenyl)-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SCC(O1)=NN=C1C1=CC(C)=CC=C1F IDNLAZRWSIDOAH-UHFFFAOYSA-N 0.000 claims 1
- GICJXFMWFZVMFF-UHFFFAOYSA-N 2-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(3-nitrophenyl)-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SCC(O1)=NN=C1C1=CC=CC([N+]([O-])=O)=C1 GICJXFMWFZVMFF-UHFFFAOYSA-N 0.000 claims 1
- NHLRJWHMULKPEG-UHFFFAOYSA-N 2-[1-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-5-(2-methylpyridin-4-yl)-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=C(C)N=CC=2)OC=1C(C)SC(N1C2CC2)=NN=C1C1=CC=NC=C1 NHLRJWHMULKPEG-UHFFFAOYSA-N 0.000 claims 1
- HUVYFWDAHBIMRN-UHFFFAOYSA-N 2-[1-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]-2-methylpropan-2-yl]-5-pyridin-4-yl-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)OC=1C(C)(C)CC(ON=1)=NC=1C1=CC=CC(Cl)=C1 HUVYFWDAHBIMRN-UHFFFAOYSA-N 0.000 claims 1
- HJKDGITWOQICHW-UHFFFAOYSA-N 2-[1-[[5-(3-fluorophenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]ethyl]-5-(2-methylpyridin-4-yl)-1,3,4-oxadiazole Chemical compound N=1N=C(C=2C=C(C)N=CC=2)OC=1C(C)SC(N1C)=NN=C1C1=CC=CC(F)=C1 HJKDGITWOQICHW-UHFFFAOYSA-N 0.000 claims 1
- BRNPQSMFSBIADD-UHFFFAOYSA-N 2-[1-[[5-(4-methoxyphenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]ethyl]-5-(2-methylpyridin-4-yl)-1,3,4-oxadiazole Chemical compound C1=CC(OC)=CC=C1C(N1C)=NN=C1SC(C)C1=NN=C(C=2C=C(C)N=CC=2)O1 BRNPQSMFSBIADD-UHFFFAOYSA-N 0.000 claims 1
- PXWMLTUYZVBNGV-UHFFFAOYSA-N 2-[2-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]-2-methylpropyl]-5-pyridin-4-yl-1,3,4-oxadiazole Chemical compound N=1C(C=2C=C(Cl)C=CC=2)=NOC=1C(C)(C)CC(O1)=NN=C1C1=CC=NC=C1 PXWMLTUYZVBNGV-UHFFFAOYSA-N 0.000 claims 1
- AQGQZHXNWYNUEI-UHFFFAOYSA-N 2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(3-nitrophenyl)-1,3,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(O1)=NN=C1C1=CC=CC([N+]([O-])=O)=C1 AQGQZHXNWYNUEI-UHFFFAOYSA-N 0.000 claims 1
- VQMFCMDRYLAJTR-UHFFFAOYSA-N 2-[[5-(3-methylphenyl)-1,2,4-oxadiazol-3-yl]methylsulfanyl]-5-(2-methyl-1,3-thiazol-4-yl)-1,3,4-oxadiazole Chemical compound S1C(C)=NC(C=2OC(SCC=3N=C(ON=3)C=3C=C(C)C=CC=3)=NN=2)=C1 VQMFCMDRYLAJTR-UHFFFAOYSA-N 0.000 claims 1
- LNVWRBNPXCUYJI-UHFFFAOYSA-N 3,5-dimethyl-1h-pyrazol-4-amine Chemical compound CC1=NNC(C)=C1N LNVWRBNPXCUYJI-UHFFFAOYSA-N 0.000 claims 1
- ALSZVEHDVVVPNN-UHFFFAOYSA-N 3-(1h-benzimidazol-2-ylsulfanylmethyl)-5-(2-methylpyridin-4-yl)-1,2,4-oxadiazole Chemical compound C1=NC(C)=CC(C=2ON=C(CSC=3NC4=CC=CC=C4N=3)N=2)=C1 ALSZVEHDVVVPNN-UHFFFAOYSA-N 0.000 claims 1
- PWLKNSZTBIQRQB-UHFFFAOYSA-N 3-(1h-benzimidazol-2-ylsulfanylmethyl)-5-(3-bromophenyl)-1,2,4-oxadiazole Chemical compound BrC1=CC=CC(C=2ON=C(CSC=3NC4=CC=CC=C4N=3)N=2)=C1 PWLKNSZTBIQRQB-UHFFFAOYSA-N 0.000 claims 1
- JDIGJDHRJKIHND-UHFFFAOYSA-N 3-(1h-benzimidazol-2-ylsulfanylmethyl)-5-(3-iodophenyl)-1,2,4-oxadiazole Chemical compound IC1=CC=CC(C=2ON=C(CSC=3NC4=CC=CC=C4N=3)N=2)=C1 JDIGJDHRJKIHND-UHFFFAOYSA-N 0.000 claims 1
- XCFRLZNSQHJQTF-UHFFFAOYSA-N 3-(1h-benzimidazol-2-ylsulfanylmethyl)-5-[3-(methoxymethyl)phenyl]-1,2,4-oxadiazole Chemical compound COCC1=CC=CC(C=2ON=C(CSC=3NC4=CC=CC=C4N=3)N=2)=C1 XCFRLZNSQHJQTF-UHFFFAOYSA-N 0.000 claims 1
- PQJRLGVEHBARMI-UHFFFAOYSA-N 3-(2,5-difluorophenyl)-5-[(4-ethyl-5-pyrimidin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2N=CN=CC=2)N(CC)C=1SCC(ON=1)=NC=1C1=CC(F)=CC=C1F PQJRLGVEHBARMI-UHFFFAOYSA-N 0.000 claims 1
- SOBVQBQYECNUMJ-UHFFFAOYSA-N 3-(2,5-difluorophenyl)-5-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(ON=1)=NC=1C1=CC(F)=CC=C1F SOBVQBQYECNUMJ-UHFFFAOYSA-N 0.000 claims 1
- RIJNQCHNXCZMKB-UHFFFAOYSA-N 3-(2-fluoro-5-methylphenyl)-5-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=C(F)C(C=2N=C(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C)ON=2)=C1 RIJNQCHNXCZMKB-UHFFFAOYSA-N 0.000 claims 1
- GUNNUISZJWGLPH-UHFFFAOYSA-N 3-(2-methylphenyl)-5-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=CC=C1C1=NOC(CSC=2N(C(C=3SC=CC=3)=NN=2)C)=N1 GUNNUISZJWGLPH-UHFFFAOYSA-N 0.000 claims 1
- JZRPLPJPWQASHV-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound ClC1=CC=CC(C=2N=C(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)ON=2)=C1 JZRPLPJPWQASHV-UHFFFAOYSA-N 0.000 claims 1
- UXFFNAMXSRIODG-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(ON=1)=NC=1C1=CC=CC(Cl)=C1 UXFFNAMXSRIODG-UHFFFAOYSA-N 0.000 claims 1
- FNLOIGQULBNMQP-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2-oxazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(ON=1)=CC=1C1=CC=CC(Cl)=C1 FNLOIGQULBNMQP-UHFFFAOYSA-N 0.000 claims 1
- QFTBNUNXKAXLBR-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1SCC(ON=1)=NC=1C1=CC=CC(Cl)=C1 QFTBNUNXKAXLBR-UHFFFAOYSA-N 0.000 claims 1
- BZBIEHOOZOUBAR-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(ON=1)=NC=1C1=CC=CC(Cl)=C1 BZBIEHOOZOUBAR-UHFFFAOYSA-N 0.000 claims 1
- WSPTYMZKDVUCBU-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[1-(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)-2-methylpropan-2-yl]-1,2,4-oxadiazole Chemical compound N=1C(C=2C=C(Cl)C=CC=2)=NOC=1C(C)(C)CC(N1C2CC2)=NN=C1C1=CC=NC=C1 WSPTYMZKDVUCBU-UHFFFAOYSA-N 0.000 claims 1
- KUYCYNUMZRIFDV-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[1-(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)propan-2-yl]-1,2,4-oxadiazole Chemical compound N=1C(C=2C=C(Cl)C=CC=2)=NOC=1C(C)CC(N1C2CC2)=NN=C1C1=CC=NC=C1 KUYCYNUMZRIFDV-UHFFFAOYSA-N 0.000 claims 1
- ZJIMPQCIJQCMQE-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[1-(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)propan-2-yl]-1,2,4-oxadiazole Chemical compound N=1C(C=2C=C(Cl)C=CC=2)=NOC=1C(C)CC(N1C)=NN=C1C1=CC=NC=C1 ZJIMPQCIJQCMQE-UHFFFAOYSA-N 0.000 claims 1
- NOJWPQNURDKXMO-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[1-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)oxy]ethyl]-1,2-oxazole Chemical compound C=1C(C=2C=C(Cl)C=CC=2)=NOC=1C(C)OC(N1C)=NN=C1C1=CC=NC=C1 NOJWPQNURDKXMO-UHFFFAOYSA-N 0.000 claims 1
- HTWHUFJONAEYKY-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[1-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1C(C=2C=C(Cl)C=CC=2)=NOC=1C(C)SC(N1C)=NN=C1C1=CC=NC=C1 HTWHUFJONAEYKY-UHFFFAOYSA-N 0.000 claims 1
- LCTIMOQCBMOIAW-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[2-(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)cyclopropyl]-1,2,4-oxadiazole Chemical compound ClC1=CC=CC(C=2N=C(ON=2)C2C(C2)C=2N(C(C=3C=CN=CC=3)=NN=2)C2CC2)=C1 LCTIMOQCBMOIAW-UHFFFAOYSA-N 0.000 claims 1
- IFMMDQRNCVFTLK-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[2-(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)ethyl]-1,2,4-oxadiazole Chemical compound ClC1=CC=CC(C=2N=C(CCC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)ON=2)=C1 IFMMDQRNCVFTLK-UHFFFAOYSA-N 0.000 claims 1
- NAFIDOLZYHPDSM-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[2-(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)ethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1CCC(ON=1)=NC=1C1=CC=CC(Cl)=C1 NAFIDOLZYHPDSM-UHFFFAOYSA-N 0.000 claims 1
- IOUHUSIUZLAMGF-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[2-(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)cyclopropyl]-1,2,4-oxadiazole Chemical compound CN1C(C2C(C2)C=2ON=C(N=2)C=2C=C(Cl)C=CC=2)=NN=C1C1=CC=NC=C1 IOUHUSIUZLAMGF-UHFFFAOYSA-N 0.000 claims 1
- XYLNZHYOJGDSAC-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[2-(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)ethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1CCC(ON=1)=NC=1C1=CC=CC(Cl)=C1 XYLNZHYOJGDSAC-UHFFFAOYSA-N 0.000 claims 1
- LFDFYNANDJGZCR-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[2-(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)ethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1CCC(ON=1)=NC=1C1=CC=CC(Cl)=C1 LFDFYNANDJGZCR-UHFFFAOYSA-N 0.000 claims 1
- RGMYQYGESKXZBN-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[[4-ethyl-5-(methylsulfanylmethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CCN1C(CSC)=NN=C1SCC1=NC(C=2C=C(Cl)C=CC=2)=NO1 RGMYQYGESKXZBN-UHFFFAOYSA-N 0.000 claims 1
- RUCVRCTZWPZUTH-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[[4-ethyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N1=C(C(F)(F)F)N(CC)C(SCC=2ON=C(N=2)C=2C=C(Cl)C=CC=2)=N1 RUCVRCTZWPZUTH-UHFFFAOYSA-N 0.000 claims 1
- ACVSTHCPAPIYDN-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[[4-ethyl-5-[(4-methoxyphenoxy)methyl]-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(SCC=2ON=C(N=2)C=2C=C(Cl)C=CC=2)N(CC)C=1COC1=CC=C(OC)C=C1 ACVSTHCPAPIYDN-UHFFFAOYSA-N 0.000 claims 1
- ZBFQBILIYJQZOW-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[[5-(ethoxymethyl)-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CCN1C(COCC)=NN=C1SCC1=NC(C=2C=C(Cl)C=CC=2)=NO1 ZBFQBILIYJQZOW-UHFFFAOYSA-N 0.000 claims 1
- WISWIDXXUHKWMX-UHFFFAOYSA-N 3-(3-chlorophenyl)-5-[[5-(furan-2-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(C)C=1SCC(ON=1)=NC=1C1=CC=CC(Cl)=C1 WISWIDXXUHKWMX-UHFFFAOYSA-N 0.000 claims 1
- CQXIJJPPNZKAFD-UHFFFAOYSA-N 3-(3-fluorophenyl)-5-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1SCC(ON=1)=NC=1C1=CC=CC(F)=C1 CQXIJJPPNZKAFD-UHFFFAOYSA-N 0.000 claims 1
- GJCVUPPYXAASGG-UHFFFAOYSA-N 3-(3-methylphenyl)-5-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=CC(C=2N=C(CSC=3N(C(C=4SC=CC=4)=NN=3)C)ON=2)=C1 GJCVUPPYXAASGG-UHFFFAOYSA-N 0.000 claims 1
- ZJMVLSWIGSHZHI-UHFFFAOYSA-N 3-(5-chloro-2-fluorophenyl)-5-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(ON=1)=NC=1C1=CC(Cl)=CC=C1F ZJMVLSWIGSHZHI-UHFFFAOYSA-N 0.000 claims 1
- RXYYCGOGFOINBA-UHFFFAOYSA-N 3-(5-chloro-2-fluorophenyl)-5-[[4-(cyclopropylmethyl)-5-thiophen-2-yl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound FC1=CC=C(Cl)C=C1C1=NOC(CSC=2N(C(C=3SC=CC=3)=NN=2)CC2CC2)=N1 RXYYCGOGFOINBA-UHFFFAOYSA-N 0.000 claims 1
- JCBYWLBIPVXKPC-UHFFFAOYSA-N 3-(5-chloro-2-fluorophenyl)-5-[[4-ethyl-5-(methoxymethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CCN1C(COC)=NN=C1SCC1=NC(C=2C(=CC=C(Cl)C=2)F)=NO1 JCBYWLBIPVXKPC-UHFFFAOYSA-N 0.000 claims 1
- SNMDLRDLKAGDNZ-UHFFFAOYSA-N 3-[(4-benzyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(3-chlorophenyl)-1,2,4-oxadiazole Chemical compound ClC1=CC=CC(C=2ON=C(CSC=3N(C(C=4SC=CC=4)=NN=3)CC=3C=CC=CC=3)N=2)=C1 SNMDLRDLKAGDNZ-UHFFFAOYSA-N 0.000 claims 1
- ZYOFGBAKTWEHNT-UHFFFAOYSA-N 3-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(2,5-difluorophenyl)-1,2,4-oxadiazole Chemical compound FC1=CC=C(F)C(C=2ON=C(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)N=2)=C1 ZYOFGBAKTWEHNT-UHFFFAOYSA-N 0.000 claims 1
- SVAIDTVRJMDBHH-UHFFFAOYSA-N 3-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(2-fluoro-5-methylphenyl)-1,2,4-oxadiazole Chemical compound CC1=CC=C(F)C(C=2ON=C(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)N=2)=C1 SVAIDTVRJMDBHH-UHFFFAOYSA-N 0.000 claims 1
- IHCOSKDYZAGVTK-UHFFFAOYSA-N 3-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(3-methylphenyl)-1,2,4-oxadiazole Chemical compound CC1=CC=CC(C=2ON=C(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)N=2)=C1 IHCOSKDYZAGVTK-UHFFFAOYSA-N 0.000 claims 1
- LCFYKTWHSMUQFI-UHFFFAOYSA-N 3-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(2-fluoro-5-methylphenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(C)=CC=C1F LCFYKTWHSMUQFI-UHFFFAOYSA-N 0.000 claims 1
- LMFGNMOASRUESG-UHFFFAOYSA-N 3-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(3-methylphenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(C)=C1 LMFGNMOASRUESG-UHFFFAOYSA-N 0.000 claims 1
- HTPRNZYVTWGLBD-UHFFFAOYSA-N 3-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-phenyl-1,2-oxazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SCC(=NO1)C=C1C1=CC=CC=C1 HTPRNZYVTWGLBD-UHFFFAOYSA-N 0.000 claims 1
- DTAQYOBEWOMNDV-UHFFFAOYSA-N 3-[(4-ethyl-5-pyrimidin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(2-fluoro-5-methylphenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2N=CN=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(C)=CC=C1F DTAQYOBEWOMNDV-UHFFFAOYSA-N 0.000 claims 1
- PGIFJCVNLPLFAZ-UHFFFAOYSA-N 3-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(3-fluorophenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(F)=C1 PGIFJCVNLPLFAZ-UHFFFAOYSA-N 0.000 claims 1
- GLLWNYQMXPZTPQ-UHFFFAOYSA-N 3-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-thiophen-2-yl-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CS1 GLLWNYQMXPZTPQ-UHFFFAOYSA-N 0.000 claims 1
- CVXRHUNISRPCFO-UHFFFAOYSA-N 3-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-thiophen-3-yl-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C=1C=CSC=1 CVXRHUNISRPCFO-UHFFFAOYSA-N 0.000 claims 1
- XVTHWPZTJNHYHV-UHFFFAOYSA-N 3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-phenyl-1,2-oxazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1SCC(=NO1)C=C1C1=CC=CC=C1 XVTHWPZTJNHYHV-UHFFFAOYSA-N 0.000 claims 1
- IUDYUIPBHQIEPN-UHFFFAOYSA-N 3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(3-nitrophenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC([N+]([O-])=O)=C1 IUDYUIPBHQIEPN-UHFFFAOYSA-N 0.000 claims 1
- MJANABQYSNCKOD-UHFFFAOYSA-N 3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-thiophen-2-yl-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CS1 MJANABQYSNCKOD-UHFFFAOYSA-N 0.000 claims 1
- UYJHUQQPNAGAHP-UHFFFAOYSA-N 3-[(4-methyl-5-thiophen-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-phenyl-1,2-oxazole Chemical compound N=1N=C(C2=CSC=C2)N(C)C=1SCC(=NO1)C=C1C1=CC=CC=C1 UYJHUQQPNAGAHP-UHFFFAOYSA-N 0.000 claims 1
- XJHOPNAINISQFJ-UHFFFAOYSA-N 3-[(4-methyl-5-thiophen-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-thiophen-3-yl-1,2,4-oxadiazole Chemical compound N=1N=C(C2=CSC=C2)N(C)C=1SCC(N=1)=NOC=1C=1C=CSC=1 XJHOPNAINISQFJ-UHFFFAOYSA-N 0.000 claims 1
- JIJJCAHLKXWPIO-UHFFFAOYSA-N 3-[(5-cyclohexyl-4-methyl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(3-methylphenyl)-1,2,4-oxadiazole Chemical compound CC1=CC=CC(C=2ON=C(CSC=3N(C(C4CCCCC4)=NN=3)C)N=2)=C1 JIJJCAHLKXWPIO-UHFFFAOYSA-N 0.000 claims 1
- MQUMFIKZVRCOQS-UHFFFAOYSA-N 3-[(5-tert-butyl-4-methyl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-(3-methylphenyl)-1,2,4-oxadiazole Chemical compound CC1=CC=CC(C=2ON=C(CSC=3N(C(=NN=3)C(C)(C)C)C)N=2)=C1 MQUMFIKZVRCOQS-UHFFFAOYSA-N 0.000 claims 1
- WAQWXEICNGCCRK-UHFFFAOYSA-N 3-[1-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-5-(2,5-difluorophenyl)-1,2,4-oxadiazole Chemical compound N=1OC(C=2C(=CC=C(F)C=2)F)=NC=1C(C)SC(N1C2CC2)=NN=C1C1=CC=NC=C1 WAQWXEICNGCCRK-UHFFFAOYSA-N 0.000 claims 1
- DVDPTDIRIYOADX-UHFFFAOYSA-N 3-[1-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-5-(2-fluoro-5-methylphenyl)-1,2,4-oxadiazole Chemical compound N=1OC(C=2C(=CC=C(C)C=2)F)=NC=1C(C)SC(N1C2CC2)=NN=C1C1=CC=NC=C1 DVDPTDIRIYOADX-UHFFFAOYSA-N 0.000 claims 1
- ZQIDMOGLBZEEIM-UHFFFAOYSA-N 3-[1-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-5-(3-fluorophenyl)-1,2,4-oxadiazole Chemical compound N=1OC(C=2C=C(F)C=CC=2)=NC=1C(C)SC(N1C2CC2)=NN=C1C1=CC=NC=C1 ZQIDMOGLBZEEIM-UHFFFAOYSA-N 0.000 claims 1
- DQTFPYFZUBMEDT-UHFFFAOYSA-N 3-[1-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-5-(3-methylphenyl)-1,2,4-oxadiazole Chemical compound N=1OC(C=2C=C(C)C=CC=2)=NC=1C(C)SC(N1C2CC2)=NN=C1C1=CC=NC=C1 DQTFPYFZUBMEDT-UHFFFAOYSA-N 0.000 claims 1
- OGIZMIONSLCTKT-UHFFFAOYSA-N 3-[1-[[4-(cyclopropylmethyl)-5-pyridin-4-yl-1,2,4-triazol-3-yl]sulfanyl]ethyl]-5-(2-fluoro-5-methylphenyl)-1,2-oxazole Chemical compound C1=C(C=2C(=CC=C(C)C=2)F)ON=C1C(C)SC(N1CC2CC2)=NN=C1C1=CC=NC=C1 OGIZMIONSLCTKT-UHFFFAOYSA-N 0.000 claims 1
- SIYIEVRUGAYZHY-UHFFFAOYSA-N 3-[1-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-5-(2-fluoro-5-methylphenyl)-1,2-oxazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SC(C)C(=NO1)C=C1C1=CC(C)=CC=C1F SIYIEVRUGAYZHY-UHFFFAOYSA-N 0.000 claims 1
- PBPPFOCDCUHKMZ-UHFFFAOYSA-N 3-[3-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazol-5-yl]-4-fluorobenzonitrile Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(C#N)=CC=C1F PBPPFOCDCUHKMZ-UHFFFAOYSA-N 0.000 claims 1
- VVRIILSXUCXWNR-UHFFFAOYSA-N 3-[3-[(4-methyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazol-5-yl]benzonitrile Chemical compound N=1N=C(C=2C=NC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(C#N)=C1 VVRIILSXUCXWNR-UHFFFAOYSA-N 0.000 claims 1
- GEEYWQSZCYHWSK-UHFFFAOYSA-N 3-[3-[1-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazol-5-yl]benzonitrile Chemical compound N=1OC(C=2C=C(C=CC=2)C#N)=NC=1C(C)SC(N1C2CC2)=NN=C1C1=CC=NC=C1 GEEYWQSZCYHWSK-UHFFFAOYSA-N 0.000 claims 1
- DLUHXUCDPDOJHF-UHFFFAOYSA-N 3-[3-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazol-5-yl]-4-fluorobenzonitrile Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(C#N)=CC=C1F DLUHXUCDPDOJHF-UHFFFAOYSA-N 0.000 claims 1
- GNTZEZVCXPKVKD-UHFFFAOYSA-N 3-[3-[[4-ethyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazol-5-yl]benzonitrile Chemical compound N1=C(C(F)(F)F)N(CC)C(SCC=2N=C(ON=2)C=2C=C(C=CC=2)C#N)=N1 GNTZEZVCXPKVKD-UHFFFAOYSA-N 0.000 claims 1
- AZNZAOBELWKZHL-UHFFFAOYSA-N 3-[3-[[4-methyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazol-5-yl]benzonitrile Chemical compound N1=C(C(F)(F)F)N(C)C(SCC=2N=C(ON=2)C=2C=C(C=CC=2)C#N)=N1 AZNZAOBELWKZHL-UHFFFAOYSA-N 0.000 claims 1
- STQBZQOSJUYHTL-UHFFFAOYSA-N 3-[5-[(1-methyl-5-thiophen-2-ylimidazol-2-yl)sulfanylmethyl]-1,2,4-oxadiazol-3-yl]benzonitrile Chemical compound N=1C=C(C=2SC=CC=2)N(C)C=1SCC(ON=1)=NC=1C1=CC=CC(C#N)=C1 STQBZQOSJUYHTL-UHFFFAOYSA-N 0.000 claims 1
- CRMGZBRRWORXLV-UHFFFAOYSA-N 3-[5-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]benzonitrile Chemical compound N#CC1=CC=CC(C=2OC(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)=NN=2)=C1 CRMGZBRRWORXLV-UHFFFAOYSA-N 0.000 claims 1
- RWZZJCSNTLCCDO-UHFFFAOYSA-N 3-[5-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]benzonitrile Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1SCC(O1)=NN=C1C1=CC=CC(C#N)=C1 RWZZJCSNTLCCDO-UHFFFAOYSA-N 0.000 claims 1
- BFRGHHKUZKLBQA-UHFFFAOYSA-N 3-[5-[2-[5-(3-aminophenyl)-1,3,4-oxadiazol-2-yl]ethyl]-1,3,4-oxadiazol-2-yl]aniline Chemical compound NC1=CC=CC(C=2OC(CCC=3OC(=NN=3)C=3C=C(N)C=CC=3)=NN=2)=C1 BFRGHHKUZKLBQA-UHFFFAOYSA-N 0.000 claims 1
- HWOJYUHKDNSDDO-UHFFFAOYSA-N 3-[5-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazol-3-yl]benzonitrile Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(ON=1)=NC=1C1=CC=CC(C#N)=C1 HWOJYUHKDNSDDO-UHFFFAOYSA-N 0.000 claims 1
- AMNDZVBPKAIDOO-UHFFFAOYSA-N 3-[5-[[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]methylsulfanyl]-4-methyl-1,2,4-triazol-3-yl]benzonitrile Chemical compound N=1N=C(C=2C=C(C=CC=2)C#N)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 AMNDZVBPKAIDOO-UHFFFAOYSA-N 0.000 claims 1
- QHRXUELISNBICD-UHFFFAOYSA-N 3-[[4-ethyl-5-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(2-methylpyridin-4-yl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CC(C)=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=NC(C)=C1 QHRXUELISNBICD-UHFFFAOYSA-N 0.000 claims 1
- PVKPORQZIUVEPY-UHFFFAOYSA-N 3-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(4-methylthiophen-2-yl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(C)=CS1 PVKPORQZIUVEPY-UHFFFAOYSA-N 0.000 claims 1
- FZTZVZJUZIFHLA-UHFFFAOYSA-N 3-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-thiophen-3-yl-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C=1C=CSC=1 FZTZVZJUZIFHLA-UHFFFAOYSA-N 0.000 claims 1
- HPEAXFXUBSWABK-UHFFFAOYSA-N 3-[[4-ethyl-5-(furan-3-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(2-fluoro-5-methylphenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C2=COC=C2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(C)=CC=C1F HPEAXFXUBSWABK-UHFFFAOYSA-N 0.000 claims 1
- OREMJJAOKOEIFU-UHFFFAOYSA-N 3-[[4-ethyl-5-(methoxymethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(3-methylphenyl)-1,2,4-oxadiazole Chemical compound CCN1C(COC)=NN=C1SCC1=NOC(C=2C=C(C)C=CC=2)=N1 OREMJJAOKOEIFU-UHFFFAOYSA-N 0.000 claims 1
- ARXYFZYKBCCUMR-UHFFFAOYSA-N 3-[[4-ethyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(3-methoxyphenyl)-1,2,4-oxadiazole Chemical compound N1=C(C(F)(F)F)N(CC)C(SCC=2N=C(ON=2)C=2C=C(OC)C=CC=2)=N1 ARXYFZYKBCCUMR-UHFFFAOYSA-N 0.000 claims 1
- DHCHFMGRXAWVOG-UHFFFAOYSA-N 3-[[4-ethyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-thiophen-2-yl-1,2,4-oxadiazole Chemical compound N1=C(C(F)(F)F)N(CC)C(SCC=2N=C(ON=2)C=2SC=CC=2)=N1 DHCHFMGRXAWVOG-UHFFFAOYSA-N 0.000 claims 1
- JUGSSLMMDKKBIJ-UHFFFAOYSA-N 3-[[4-ethyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-thiophen-3-yl-1,2-oxazole Chemical compound N1=C(C(F)(F)F)N(CC)C(SCC2=NOC(=C2)C2=CSC=C2)=N1 JUGSSLMMDKKBIJ-UHFFFAOYSA-N 0.000 claims 1
- PRVXOHJIVSNPRK-UHFFFAOYSA-N 3-[[5-(1,3-benzodioxol-5-yl)-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(3-chlorophenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=C3OCOC3=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 PRVXOHJIVSNPRK-UHFFFAOYSA-N 0.000 claims 1
- BADPRUOGQDHEKU-UHFFFAOYSA-N 3-[[5-(1-benzothiophen-2-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(3-chlorophenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC3=CC=CC=C3C=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 BADPRUOGQDHEKU-UHFFFAOYSA-N 0.000 claims 1
- FIEJUAQHJUFAMD-UHFFFAOYSA-N 3-[[5-(2-chloro-6-methoxypyridin-4-yl)-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(3-chlorophenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=C(OC)N=C(Cl)C=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 FIEJUAQHJUFAMD-UHFFFAOYSA-N 0.000 claims 1
- VQPQVMZZQPQVEG-UHFFFAOYSA-N 3-[[5-(2-chloro-6-methylpyridin-4-yl)-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(3-chlorophenyl)-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=C(Cl)N=C(C)C=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 VQPQVMZZQPQVEG-UHFFFAOYSA-N 0.000 claims 1
- FBMJLDFTFHPAJZ-UHFFFAOYSA-N 3-[[5-(2-fluoro-5-methylphenyl)-1,2,4-oxadiazol-3-yl]methylsulfanyl]-5-thiophen-2-yl-1,2,4-triazol-4-amine Chemical compound CC1=CC=C(F)C(C=2ON=C(CSC=3N(C(C=4SC=CC=4)=NN=3)N)N=2)=C1 FBMJLDFTFHPAJZ-UHFFFAOYSA-N 0.000 claims 1
- HYIUYKQLRGVUQH-UHFFFAOYSA-N 3-[[5-(3-chlorophenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(2-methylpyridin-4-yl)-1,2,4-oxadiazole Chemical compound C1=NC(C)=CC(C=2ON=C(CSC=3N(C(C=4C=C(Cl)C=CC=4)=NN=3)C)N=2)=C1 HYIUYKQLRGVUQH-UHFFFAOYSA-N 0.000 claims 1
- CQNVDDZGEIFOIF-UHFFFAOYSA-N 3-[[5-(3-methylphenyl)-1,2,4-oxadiazol-3-yl]methylsulfanyl]-5-pyridin-4-yl-1,2,4-triazol-4-amine Chemical compound CC1=CC=CC(C=2ON=C(CSC=3N(C(C=4C=CN=CC=4)=NN=3)N)N=2)=C1 CQNVDDZGEIFOIF-UHFFFAOYSA-N 0.000 claims 1
- VYIOKIZKOCOAPW-UHFFFAOYSA-N 3-[[5-(3-methylphenyl)-1,2,4-oxadiazol-3-yl]methylsulfanyl]-5-thiophen-2-yl-1,2,4-triazol-4-amine Chemical compound CC1=CC=CC(C=2ON=C(CSC=3N(C(C=4SC=CC=4)=NN=3)N)N=2)=C1 VYIOKIZKOCOAPW-UHFFFAOYSA-N 0.000 claims 1
- FKRGSTYYNOACSK-UHFFFAOYSA-N 3-[[5-(4-methoxyphenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(2-methylpyridin-4-yl)-1,2,4-oxadiazole Chemical compound C1=CC(OC)=CC=C1C(N1C)=NN=C1SCC1=NOC(C=2C=C(C)N=CC=2)=N1 FKRGSTYYNOACSK-UHFFFAOYSA-N 0.000 claims 1
- RKXOELVELJSVAU-UHFFFAOYSA-N 3-[[5-(furan-2-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(3-methylphenyl)-1,2,4-oxadiazole Chemical compound CC1=CC=CC(C=2ON=C(CSC=3N(C(C=4OC=CC=4)=NN=3)C)N=2)=C1 RKXOELVELJSVAU-UHFFFAOYSA-N 0.000 claims 1
- MVBZWPNNPCWONF-UHFFFAOYSA-N 4-[5-[1-[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]ethylsulfanyl]-4-ethyl-1,2,4-triazol-3-yl]-1h-pyridin-2-one Chemical compound N=1N=C(C=2C=C(O)N=CC=2)N(CC)C=1SC(C)C(N=1)=NOC=1C1=CC=CC(Cl)=C1 MVBZWPNNPCWONF-UHFFFAOYSA-N 0.000 claims 1
- SJRCCWOQNRYTER-UHFFFAOYSA-N 4-[5-[1-[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]ethylsulfanyl]-4-ethyl-1,2,4-triazol-3-yl]phenol Chemical compound N=1N=C(C=2C=CC(O)=CC=2)N(CC)C=1SC(C)C(N=1)=NOC=1C1=CC=CC(Cl)=C1 SJRCCWOQNRYTER-UHFFFAOYSA-N 0.000 claims 1
- RATCIARNOFMTDH-UHFFFAOYSA-N 4-[[5-[[5-(5-chloro-2-fluorophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-ethyl-1,2,4-triazol-3-yl]methoxy]phenol Chemical compound N=1N=C(SCC=2OC(=NN=2)C=2C(=CC=C(Cl)C=2)F)N(CC)C=1COC1=CC=C(O)C=C1 RATCIARNOFMTDH-UHFFFAOYSA-N 0.000 claims 1
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 claims 1
- RBDPMSWQNRTZMY-UHFFFAOYSA-N 4-chloro-2-[3-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazol-5-yl]phenol Chemical compound OC1=CC=C(Cl)C=C1C1=NC(CSC=2N(C(C=3C=CN=CC=3)=NN=2)C2CC2)=NO1 RBDPMSWQNRTZMY-UHFFFAOYSA-N 0.000 claims 1
- QWSIJYXSIURKJT-UHFFFAOYSA-N 4-chloro-5-(3-chlorophenyl)-3-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2-oxazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SCC(C=1Cl)=NOC=1C1=CC=CC(Cl)=C1 QWSIJYXSIURKJT-UHFFFAOYSA-N 0.000 claims 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 claims 1
- SNDVAXXDGZQBTC-UHFFFAOYSA-N 5-(2,5-dichlorophenyl)-3-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(Cl)=CC=C1Cl SNDVAXXDGZQBTC-UHFFFAOYSA-N 0.000 claims 1
- AHCMYYLLGYTVLO-UHFFFAOYSA-N 5-(2,5-dichlorophenyl)-3-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(Cl)=CC=C1Cl AHCMYYLLGYTVLO-UHFFFAOYSA-N 0.000 claims 1
- UXBNBHRSFIXHPY-UHFFFAOYSA-N 5-(2,5-difluorophenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC(F)=CC=C1F UXBNBHRSFIXHPY-UHFFFAOYSA-N 0.000 claims 1
- AREIVJHZVJORNX-UHFFFAOYSA-N 5-(2-chloro-5-methylphenyl)-3-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=C(Cl)C(C=2ON=C(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)N=2)=C1 AREIVJHZVJORNX-UHFFFAOYSA-N 0.000 claims 1
- ILMKXXLGMPJGRN-UHFFFAOYSA-N 5-(2-chloro-5-methylphenyl)-3-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(C)=CC=C1Cl ILMKXXLGMPJGRN-UHFFFAOYSA-N 0.000 claims 1
- CHFHZQPWNMXAOU-UHFFFAOYSA-N 5-(2-chloro-5-methylphenyl)-3-[1-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1OC(C=2C(=CC=C(C)C=2)Cl)=NC=1C(C)SC(N1C2CC2)=NN=C1C1=CC=NC=C1 CHFHZQPWNMXAOU-UHFFFAOYSA-N 0.000 claims 1
- VSSUYYKDCPRLPT-UHFFFAOYSA-N 5-(2-chloro-5-methylphenyl)-3-[1-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1OC(C=2C(=CC=C(C)C=2)Cl)=NC=1C(C)SC(N1C)=NN=C1C1=CC=NC=C1 VSSUYYKDCPRLPT-UHFFFAOYSA-N 0.000 claims 1
- JWCAHMYPDHKPNA-UHFFFAOYSA-N 5-(2-chloropyridin-4-yl)-3-[(4-methyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=NC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=NC(Cl)=C1 JWCAHMYPDHKPNA-UHFFFAOYSA-N 0.000 claims 1
- QWMBQXKQFQIREI-UHFFFAOYSA-N 5-(2-chloropyridin-4-yl)-3-[[5-(furan-2-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=NC(Cl)=C1 QWMBQXKQFQIREI-UHFFFAOYSA-N 0.000 claims 1
- GINZWEIVRVNTKJ-UHFFFAOYSA-N 5-(2-fluoro-5-methylphenyl)-3-[(4-methyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=C(F)C(C=2ON=C(CSC=3N(C(C=4C=NC=CC=4)=NN=3)C)N=2)=C1 GINZWEIVRVNTKJ-UHFFFAOYSA-N 0.000 claims 1
- LJMFFZPNYPVCPA-UHFFFAOYSA-N 5-(2-fluoro-5-methylphenyl)-3-[(4-propyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CCC)C=1SCC(N=1)=NOC=1C1=CC(C)=CC=C1F LJMFFZPNYPVCPA-UHFFFAOYSA-N 0.000 claims 1
- GYBNGASNFVKVRK-UHFFFAOYSA-N 5-(2-fluoro-5-methylphenyl)-3-[1-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1OC(C=2C(=CC=C(C)C=2)F)=NC=1C(C)SC(N1C)=NN=C1C1=CC=NC=C1 GYBNGASNFVKVRK-UHFFFAOYSA-N 0.000 claims 1
- LMHKLLCITQOYOY-UHFFFAOYSA-N 5-(2-fluoro-5-methylphenyl)-3-[[5-thiophen-2-yl-4-(2,2,2-trifluoroethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=C(F)C(C=2ON=C(CSC=3N(C(C=4SC=CC=4)=NN=3)CC(F)(F)F)N=2)=C1 LMHKLLCITQOYOY-UHFFFAOYSA-N 0.000 claims 1
- GYHBACOKZTUIAH-UHFFFAOYSA-N 5-(3-bromophenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Br)=C1 GYHBACOKZTUIAH-UHFFFAOYSA-N 0.000 claims 1
- NHUYKHUKVXFOPE-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(3-pyridin-4-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-yl)methyl]-1,2,4-oxadiazole Chemical compound ClC1=CC=CC(C=2ON=C(CC3C=4N(C(=NN=4)C=4C=CN=CC=4)CCC3)N=2)=C1 NHUYKHUKVXFOPE-UHFFFAOYSA-N 0.000 claims 1
- FNMQZPTVJGZDPQ-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(3-thiophen-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-yl)methyl]-1,2,4-oxadiazole Chemical compound ClC1=CC=CC(C=2ON=C(CC3C=4N(C(=NN=4)C=4SC=CC=4)CCC3)N=2)=C1 FNMQZPTVJGZDPQ-UHFFFAOYSA-N 0.000 claims 1
- AOUWEWZXPUGKLU-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound ClC1=CC=CC(C=2ON=C(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)N=2)=C1 AOUWEWZXPUGKLU-UHFFFAOYSA-N 0.000 claims 1
- OGAVRMARRNBDRE-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2-oxazole Chemical compound ClC1=CC=CC(C=2ON=C(CSC=3N(C(C=4C=CN=CC=4)=NN=3)C3CC3)C=2)=C1 OGAVRMARRNBDRE-UHFFFAOYSA-N 0.000 claims 1
- HORQHMZJONTVQS-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(4-cyclopropyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound ClC1=CC=CC(C=2ON=C(CSC=3N(C(C=4SC=CC=4)=NN=3)C3CC3)N=2)=C1 HORQHMZJONTVQS-UHFFFAOYSA-N 0.000 claims 1
- ULMGQSKSIBPAHJ-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-4-methyl-1,2-oxazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SCC(C=1C)=NOC=1C1=CC=CC(Cl)=C1 ULMGQSKSIBPAHJ-UHFFFAOYSA-N 0.000 claims 1
- YLWHPAPFZCREJV-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2-oxazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(=NO1)C=C1C1=CC=CC(Cl)=C1 YLWHPAPFZCREJV-UHFFFAOYSA-N 0.000 claims 1
- QNQHIVAERPTGGU-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(4-methyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=NC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 QNQHIVAERPTGGU-UHFFFAOYSA-N 0.000 claims 1
- PDKOTUJWDUYHBB-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 PDKOTUJWDUYHBB-UHFFFAOYSA-N 0.000 claims 1
- SZUCSNVBBXGZNK-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 SZUCSNVBBXGZNK-UHFFFAOYSA-N 0.000 claims 1
- DFJCTIBOGACAJC-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfinylmethyl]-1,2,4-oxadiazole Chemical compound CN1C(C=2SC=CC=2)=NN=C1S(=O)CC(N=1)=NOC=1C1=CC=CC(Cl)=C1 DFJCTIBOGACAJC-UHFFFAOYSA-N 0.000 claims 1
- CHCUBACSMKMDSF-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfonylmethyl]-1,2,4-oxadiazole Chemical compound CN1C(C=2SC=CC=2)=NN=C1S(=O)(=O)CC(N=1)=NOC=1C1=CC=CC(Cl)=C1 CHCUBACSMKMDSF-UHFFFAOYSA-N 0.000 claims 1
- NLEPIJCFSHIKFA-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)propan-2-yl]-1,2,4-oxadiazole Chemical compound N=1OC(C=2C=C(Cl)C=CC=2)=NC=1C(C)CC(N1C)=NN=C1C1=CC=NC=C1 NLEPIJCFSHIKFA-UHFFFAOYSA-N 0.000 claims 1
- MREUDIQEJJYDBU-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[(4-cyclopropyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)oxy]ethyl]-1,2,4-oxadiazole Chemical compound N=1OC(C=2C=C(Cl)C=CC=2)=NC=1C(C)OC(N1C2CC2)=NN=C1C1=CC=CN=C1 MREUDIQEJJYDBU-UHFFFAOYSA-N 0.000 claims 1
- UMFDBZZEMJYCGY-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[(4-cyclopropyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1OC(C=2C=C(Cl)C=CC=2)=NC=1C(C)SC(N1C2CC2)=NN=C1C1=CC=CN=C1 UMFDBZZEMJYCGY-UHFFFAOYSA-N 0.000 claims 1
- WLKBRYNLHQMHLV-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[(4-cyclopropyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1OC(C=2C=C(Cl)C=CC=2)=NC=1C(C)SC(N1C2CC2)=NN=C1C1=CC=NC=C1 WLKBRYNLHQMHLV-UHFFFAOYSA-N 0.000 claims 1
- NLPRSLMSDZRSRU-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[(4-ethyl-5-pyridazin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=NN=CC=2)N(CC)C=1SC(C)C(N=1)=NOC=1C1=CC=CC(Cl)=C1 NLPRSLMSDZRSRU-UHFFFAOYSA-N 0.000 claims 1
- LBVXPHBWWIWTCB-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SC(C)C(N=1)=NOC=1C1=CC=CC(Cl)=C1 LBVXPHBWWIWTCB-UHFFFAOYSA-N 0.000 claims 1
- AUNHYASFFYNRLA-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2-oxazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SC(C)C(=NO1)C=C1C1=CC=CC(Cl)=C1 AUNHYASFFYNRLA-UHFFFAOYSA-N 0.000 claims 1
- UQAZUBDJPBACCB-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SC(C)C(N=1)=NOC=1C1=CC=CC(Cl)=C1 UQAZUBDJPBACCB-UHFFFAOYSA-N 0.000 claims 1
- ZIWYUFSYSIOIIJ-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1OC(C=2C=C(Cl)C=CC=2)=NC=1C(C)SC(N1C)=NN=C1C1=CC=NC=C1 ZIWYUFSYSIOIIJ-UHFFFAOYSA-N 0.000 claims 1
- MTRXCIBDHOSCBZ-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1OC(C=2C=C(Cl)C=CC=2)=NC=1C(C)SC(N1C)=NN=C1C1=CC=CS1 MTRXCIBDHOSCBZ-UHFFFAOYSA-N 0.000 claims 1
- JCQBSTFDNLGNJD-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[[4-ethyl-5-(5-methoxypyrimidin-2-yl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2N=CC(OC)=CN=2)N(CC)C=1SC(C)C(N=1)=NOC=1C1=CC=CC(Cl)=C1 JCQBSTFDNLGNJD-UHFFFAOYSA-N 0.000 claims 1
- AIUOJNMQGVZQRK-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[[4-ethyl-5-(6-methoxypyridazin-3-yl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2N=NC(OC)=CC=2)N(CC)C=1SC(C)C(N=1)=NOC=1C1=CC=CC(Cl)=C1 AIUOJNMQGVZQRK-UHFFFAOYSA-N 0.000 claims 1
- PZUQKKBDVNOHDA-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[[4-ethyl-5-(6-methoxypyridin-3-yl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=NC(OC)=CC=2)N(CC)C=1SC(C)C(N=1)=NOC=1C1=CC=CC(Cl)=C1 PZUQKKBDVNOHDA-UHFFFAOYSA-N 0.000 claims 1
- BZTHTOLHSIFKKD-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[[4-ethyl-5-(pyridin-4-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(SC(C)C=2N=C(ON=2)C=2C=C(Cl)C=CC=2)N(CC)C=1CC1=CC=NC=C1 BZTHTOLHSIFKKD-UHFFFAOYSA-N 0.000 claims 1
- XYIRWYTVBNVWKW-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[1-[[5-(4-methoxyphenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound C1=CC(OC)=CC=C1C(N1C)=NN=C1SC(C)C1=NOC(C=2C=C(Cl)C=CC=2)=N1 XYIRWYTVBNVWKW-UHFFFAOYSA-N 0.000 claims 1
- CIRNTNBDCRCSLH-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound ClC1=CC=CC(C=2ON=C(CSC=3N(C=NN=3)CC=3OC=CC=3)N=2)=C1 CIRNTNBDCRCSLH-UHFFFAOYSA-N 0.000 claims 1
- MDJSXQHWRIZADP-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-(furan-2-ylmethyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound ClC1=CC=CC(C=2ON=C(CSC=3N(C(C=4C=NC=CC=4)=NN=3)CC=3OC=CC=3)N=2)=C1 MDJSXQHWRIZADP-UHFFFAOYSA-N 0.000 claims 1
- NTLNUGLBJQDOMN-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-(furan-2-ylmethyl)-5-pyridin-4-yl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound ClC1=CC=CC(C=2ON=C(CSC=3N(C(C=4C=CN=CC=4)=NN=3)CC=3OC=CC=3)N=2)=C1 NTLNUGLBJQDOMN-UHFFFAOYSA-N 0.000 claims 1
- NQXMGABOPGEKOK-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-cyclopropyl-5-[(4-methoxyphenoxy)methyl]-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound C1=CC(OC)=CC=C1OCC(N1C2CC2)=NN=C1SCC1=NOC(C=2C=C(Cl)C=CC=2)=N1 NQXMGABOPGEKOK-UHFFFAOYSA-N 0.000 claims 1
- KAWIIPXPJCVOJH-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-ethyl-5-(1-methylimidazol-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2N(C=CN=2)C)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 KAWIIPXPJCVOJH-UHFFFAOYSA-N 0.000 claims 1
- LUUFWSHXKICXOW-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-ethyl-5-(3-fluorophenyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=C(F)C=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 LUUFWSHXKICXOW-UHFFFAOYSA-N 0.000 claims 1
- VSNLCUNDVTZKFZ-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-ethyl-5-(3-methylimidazol-4-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2N(C=NC=2)C)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 VSNLCUNDVTZKFZ-UHFFFAOYSA-N 0.000 claims 1
- IJWYSMUQXXTJBR-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-ethyl-5-(3-methylphenyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=C(C)C=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 IJWYSMUQXXTJBR-UHFFFAOYSA-N 0.000 claims 1
- XLAILDSOAQVLPD-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-ethyl-5-(3-nitrophenyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=C(C=CC=2)[N+]([O-])=O)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 XLAILDSOAQVLPD-UHFFFAOYSA-N 0.000 claims 1
- FZZRQPLRRMSIOP-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-ethyl-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CC(OC)=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 FZZRQPLRRMSIOP-UHFFFAOYSA-N 0.000 claims 1
- ZAIAAFUTZQAARJ-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-ethyl-5-(5-methylthiophen-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC(C)=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 ZAIAAFUTZQAARJ-UHFFFAOYSA-N 0.000 claims 1
- DRCOBAWAQQHKJT-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 DRCOBAWAQQHKJT-UHFFFAOYSA-N 0.000 claims 1
- ZYDKXNXTAKAFBS-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[4-ethyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N1=C(C(F)(F)F)N(CC)C(SCC=2N=C(ON=2)C=2C=C(Cl)C=CC=2)=N1 ZYDKXNXTAKAFBS-UHFFFAOYSA-N 0.000 claims 1
- UQDZOTGIYXZRSA-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[5-(2,6-difluorophenyl)-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C(=CC=CC=2F)F)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 UQDZOTGIYXZRSA-UHFFFAOYSA-N 0.000 claims 1
- ZXXYMPAIPQZVCN-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[5-(2-chloropyridin-4-yl)-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=C(Cl)N=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 ZXXYMPAIPQZVCN-UHFFFAOYSA-N 0.000 claims 1
- IETQFCPBHGEOGR-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[5-(2-fluoro-5-methylphenyl)-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=C(F)C(C=2N(C(SCC=3N=C(ON=3)C=3C=C(Cl)C=CC=3)=NN=2)CC=2OC=CC=2)=C1 IETQFCPBHGEOGR-UHFFFAOYSA-N 0.000 claims 1
- JEAQZDWCHHVHRO-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[5-(3,5-difluorophenyl)-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=C(F)C=C(F)C=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 JEAQZDWCHHVHRO-UHFFFAOYSA-N 0.000 claims 1
- GAZHEXWZCDVJTL-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[5-(3-chlorophenyl)-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=C(Cl)C=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 GAZHEXWZCDVJTL-UHFFFAOYSA-N 0.000 claims 1
- WZYPJCJLMOBROL-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[5-(4-chlorophenyl)-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CC(Cl)=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 WZYPJCJLMOBROL-UHFFFAOYSA-N 0.000 claims 1
- PDKBAGLNXMCSMC-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[5-(4-fluorophenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CC(F)=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 PDKBAGLNXMCSMC-UHFFFAOYSA-N 0.000 claims 1
- MASGDNDSEABKTH-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[5-(furan-2-yl)-4-(2-methylpropyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC(C)C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 MASGDNDSEABKTH-UHFFFAOYSA-N 0.000 claims 1
- MJHHAVHSBVGCTR-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[5-(furan-2-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 MJHHAVHSBVGCTR-UHFFFAOYSA-N 0.000 claims 1
- LFSQXUARUANUES-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[[5-(furan-3-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C2=COC=C2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(Cl)=C1 LFSQXUARUANUES-UHFFFAOYSA-N 0.000 claims 1
- BYGFCZMTCNZWJT-UHFFFAOYSA-N 5-(3-cyclopropylphenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C(C=1)=CC=CC=1C1CC1 BYGFCZMTCNZWJT-UHFFFAOYSA-N 0.000 claims 1
- ULBMGQBDSKGLJX-UHFFFAOYSA-N 5-(3-ethenylphenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(C=C)=C1 ULBMGQBDSKGLJX-UHFFFAOYSA-N 0.000 claims 1
- XFDLCNGPBBBHHZ-UHFFFAOYSA-N 5-(3-fluorophenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=CC(F)=C1 XFDLCNGPBBBHHZ-UHFFFAOYSA-N 0.000 claims 1
- MKVMIOFGKYGFCO-UHFFFAOYSA-N 5-(3-methoxyphenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound COC1=CC=CC(C=2ON=C(CSC=3N(C(C=4SC=CC=4)=NN=3)C)N=2)=C1 MKVMIOFGKYGFCO-UHFFFAOYSA-N 0.000 claims 1
- FRVMWBUVCOGVLE-UHFFFAOYSA-N 5-(3-methoxyphenyl)-3-[1-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound COC1=CC=CC(C=2ON=C(N=2)C(C)SC=2N(C(C=3C=CN=CC=3)=NN=2)C)=C1 FRVMWBUVCOGVLE-UHFFFAOYSA-N 0.000 claims 1
- FGRXAEWNMKMBKB-UHFFFAOYSA-N 5-(3-methylphenyl)-3-[(4-methyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=CC(C=2ON=C(CSC=3N(C(C=4C=NC=CC=4)=NN=3)C)N=2)=C1 FGRXAEWNMKMBKB-UHFFFAOYSA-N 0.000 claims 1
- VAGLSMGLUAQQBZ-UHFFFAOYSA-N 5-(3-methylphenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=CC(C=2ON=C(CSC=3N(C(C=4SC=CC=4)=NN=3)C)N=2)=C1 VAGLSMGLUAQQBZ-UHFFFAOYSA-N 0.000 claims 1
- LZYVEFBDBOICTE-UHFFFAOYSA-N 5-(3-methylphenyl)-3-[(4-methyl-5-thiophen-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CC1=CC=CC(C=2ON=C(CSC=3N(C(C4=CSC=C4)=NN=3)C)N=2)=C1 LZYVEFBDBOICTE-UHFFFAOYSA-N 0.000 claims 1
- VZLDANZSZQMFKW-UHFFFAOYSA-N 5-(3-methylphenyl)-3-[1-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1OC(C=2C=C(C)C=CC=2)=NC=1C(C)SC(N1C)=NN=C1C1=CC=NC=C1 VZLDANZSZQMFKW-UHFFFAOYSA-N 0.000 claims 1
- ULAYCILFACEVOO-UHFFFAOYSA-N 5-(3-methylphenyl)-3-[1-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1OC(C=2C=C(C)C=CC=2)=NC=1C(C)SC(N1C)=NN=C1C1=CC=CS1 ULAYCILFACEVOO-UHFFFAOYSA-N 0.000 claims 1
- HZMWBWDNNFRJBH-UHFFFAOYSA-N 5-(3-methylsulfanylphenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound CSC1=CC=CC(C=2ON=C(CSC=3N(C(C=4SC=CC=4)=NN=3)C)N=2)=C1 HZMWBWDNNFRJBH-UHFFFAOYSA-N 0.000 claims 1
- KEFZUEAAGZNOIG-UHFFFAOYSA-N 5-(4-fluorophenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC=C(F)C=C1 KEFZUEAAGZNOIG-UHFFFAOYSA-N 0.000 claims 1
- BPPFJZYXXOIXRN-UHFFFAOYSA-N 5-(5-bromo-2-fluorophenyl)-3-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(Br)=CC=C1F BPPFJZYXXOIXRN-UHFFFAOYSA-N 0.000 claims 1
- LZOUCFFTZXXUKD-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2-oxazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SCC(=NO1)C=C1C1=CC(Cl)=CC=C1F LZOUCFFTZXXUKD-UHFFFAOYSA-N 0.000 claims 1
- RUAINULLQLGMJP-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC(Cl)=CC=C1F RUAINULLQLGMJP-UHFFFAOYSA-N 0.000 claims 1
- XAWXJNQEKWCSJO-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2-oxazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1SCC(=NO1)C=C1C1=CC(Cl)=CC=C1F XAWXJNQEKWCSJO-UHFFFAOYSA-N 0.000 claims 1
- JRMVIKDCCOXLGQ-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[(4-methyl-5-pyrimidin-4-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2N=CN=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC(Cl)=CC=C1F JRMVIKDCCOXLGQ-UHFFFAOYSA-N 0.000 claims 1
- PXGAZMDYHYSWAB-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC(Cl)=CC=C1F PXGAZMDYHYSWAB-UHFFFAOYSA-N 0.000 claims 1
- CDTYKGCCBRPRLT-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[1-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SC(C)C(N=1)=NOC=1C1=CC(Cl)=CC=C1F CDTYKGCCBRPRLT-UHFFFAOYSA-N 0.000 claims 1
- MJYWSVANIUTPEH-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[1-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2-oxazole Chemical compound N=1N=C(C=2C=CN=CC=2)N(CC)C=1SC(C)C(=NO1)C=C1C1=CC(Cl)=CC=C1F MJYWSVANIUTPEH-UHFFFAOYSA-N 0.000 claims 1
- BHQYNIIOIZMLOX-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[1-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethyl]-1,2-oxazole Chemical compound C1=C(C=2C(=CC=C(Cl)C=2)F)ON=C1C(C)SC(N1C)=NN=C1C1=CC=NC=C1 BHQYNIIOIZMLOX-UHFFFAOYSA-N 0.000 claims 1
- HROGODRDPFPGMX-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[1-[[5-(4-methoxyphenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]ethyl]-1,2,4-oxadiazole Chemical compound C1=CC(OC)=CC=C1C(N1C)=NN=C1SC(C)C1=NOC(C=2C(=CC=C(Cl)C=2)F)=N1 HROGODRDPFPGMX-UHFFFAOYSA-N 0.000 claims 1
- WVDFTTCMPPUACP-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[[3-(furan-2-yl)-6,7-dihydro-5h-[1,2,4]triazolo[4,3-a]pyrimidin-8-yl]methyl]-1,2,4-oxadiazole Chemical compound FC1=CC=C(Cl)C=C1C1=NC(CN2C=3N(C(=NN=3)C=3OC=CC=3)CCC2)=NO1 WVDFTTCMPPUACP-UHFFFAOYSA-N 0.000 claims 1
- RGVRMNJDWIZKQM-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(Cl)=CC=C1F RGVRMNJDWIZKQM-UHFFFAOYSA-N 0.000 claims 1
- GTNLJCDYZURCQV-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[[4-ethyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N1=C(C(F)(F)F)N(CC)C(SCC=2N=C(ON=2)C=2C(=CC=C(Cl)C=2)F)=N1 GTNLJCDYZURCQV-UHFFFAOYSA-N 0.000 claims 1
- WVHKNISLXRJFNH-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[[4-methyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N1=C(C(F)(F)F)N(C)C(SCC=2N=C(ON=2)C=2C(=CC=C(Cl)C=2)F)=N1 WVHKNISLXRJFNH-UHFFFAOYSA-N 0.000 claims 1
- FCMIKXTXZXALGJ-UHFFFAOYSA-N 5-(5-chloro-2-fluorophenyl)-3-[[5-(furan-2-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(C)C=1SCC(N=1)=NOC=1C1=CC(Cl)=CC=C1F FCMIKXTXZXALGJ-UHFFFAOYSA-N 0.000 claims 1
- QDZFEHYVVSJAJW-UHFFFAOYSA-N 5-(5-chlorothiophen-3-yl)-3-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2OC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CSC(Cl)=C1 QDZFEHYVVSJAJW-UHFFFAOYSA-N 0.000 claims 1
- ZOKCVZDKHOHESK-UHFFFAOYSA-N 5-(furan-3-yl)-3-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(N=1)=NOC=1C=1C=COC=1 ZOKCVZDKHOHESK-UHFFFAOYSA-N 0.000 claims 1
- GECOSSLMNIMMRT-UHFFFAOYSA-N 5-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-3-thiophen-2-yl-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(ON=1)=NC=1C1=CC=CS1 GECOSSLMNIMMRT-UHFFFAOYSA-N 0.000 claims 1
- ICSCZXJMZHSRIO-UHFFFAOYSA-N 5-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-3-phenyl-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(ON=1)=NC=1C1=CC=CC=C1 ICSCZXJMZHSRIO-UHFFFAOYSA-N 0.000 claims 1
- JGQGLZIWRWPSHI-UHFFFAOYSA-N 5-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-3-pyridin-4-yl-1,2,4-oxadiazole Chemical compound N=1N=C(C=2SC=CC=2)N(C)C=1SCC(ON=1)=NC=1C1=CC=NC=C1 JGQGLZIWRWPSHI-UHFFFAOYSA-N 0.000 claims 1
- MXFCOXNXCAQCDO-UHFFFAOYSA-N 5-[(4-methyl-5-thiophen-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-3-phenyl-1,2,4-oxadiazole Chemical compound N=1N=C(C2=CSC=C2)N(C)C=1SCC(ON=1)=NC=1C1=CC=CC=C1 MXFCOXNXCAQCDO-UHFFFAOYSA-N 0.000 claims 1
- ZVZBHEZUCAZFQV-UHFFFAOYSA-N 5-[(4-methyl-5-thiophen-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-3-thiophen-2-yl-1,2,4-oxadiazole Chemical compound N=1N=C(C2=CSC=C2)N(C)C=1SCC(ON=1)=NC=1C1=CC=CS1 ZVZBHEZUCAZFQV-UHFFFAOYSA-N 0.000 claims 1
- WMGYPIZNFRBQNI-UHFFFAOYSA-N 5-[(4-methyl-5-thiophen-3-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-3-thiophen-3-yl-1,2,4-oxadiazole Chemical compound N=1N=C(C2=CSC=C2)N(C)C=1SCC(ON=1)=NC=1C=1C=CSC=1 WMGYPIZNFRBQNI-UHFFFAOYSA-N 0.000 claims 1
- YKCAOHODYRHOEV-UHFFFAOYSA-N 5-[(5-bromo-4-methyl-1,2,4-triazol-3-yl)sulfanylmethyl]-3-(3-chlorophenyl)-1,2,4-oxadiazole Chemical compound CN1C(Br)=NN=C1SCC1=NC(C=2C=C(Cl)C=CC=2)=NO1 YKCAOHODYRHOEV-UHFFFAOYSA-N 0.000 claims 1
- SXMMVTSIBKORJO-UHFFFAOYSA-N 5-[3-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazol-5-yl]thiophene-3-carbonitrile Chemical compound N=1N=C(C=2SC=CC=2)N(CC)C=1SCC(N=1)=NOC=1C1=CC(C#N)=CS1 SXMMVTSIBKORJO-UHFFFAOYSA-N 0.000 claims 1
- FHZUMSXYPWNPPX-UHFFFAOYSA-N 5-[[4-ethyl-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-3-thiophen-2-yl-1,2,4-oxadiazole Chemical compound N1=C(C(F)(F)F)N(CC)C(SCC=2ON=C(N=2)C=2SC=CC=2)=N1 FHZUMSXYPWNPPX-UHFFFAOYSA-N 0.000 claims 1
- 101100167062 Caenorhabditis elegans chch-3 gene Proteins 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- YLQITIKKMMQSIB-UHFFFAOYSA-N methyl 2-[3-[[5-(2-fluoro-5-methylphenyl)-1,2,4-oxadiazol-3-yl]methylsulfanyl]-5-thiophen-2-yl-1,2,4-triazol-4-yl]acetate Chemical compound N=1N=C(C=2SC=CC=2)N(CC(=O)OC)C=1SCC(N=1)=NOC=1C1=CC(C)=CC=C1F YLQITIKKMMQSIB-UHFFFAOYSA-N 0.000 claims 1
- KVPKPPYIWUTTFR-UHFFFAOYSA-N methyl 5-[[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]methylsulfanyl]-4-ethyl-1,2,4-triazole-3-carboxylate Chemical compound N1=C(C(=O)OC)N(CC)C(SCC=2ON=C(N=2)C=2C=C(Cl)C=CC=2)=N1 KVPKPPYIWUTTFR-UHFFFAOYSA-N 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 6
- 210000003169 central nervous system Anatomy 0.000 description 6
- 229930195712 glutamate Natural products 0.000 description 6
- 210000002569 neuron Anatomy 0.000 description 6
- 230000005284 excitation Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 230000001242 postsynaptic effect Effects 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
- 102000014384 Type C Phospholipases Human genes 0.000 description 2
- 108010079194 Type C Phospholipases Proteins 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- ZOOGRGPOEVQQDX-KHLHZJAASA-N cyclic guanosine monophosphate Chemical compound C([C@H]1O2)O[P@](O)(=O)O[C@@H]1[C@H](O)[C@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-KHLHZJAASA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 150000003906 phosphoinositides Chemical class 0.000 description 2
- 230000003518 presynaptic effect Effects 0.000 description 2
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- JJDNUCCDEXEKEM-UHFFFAOYSA-N 2-[5-(2,4-dibromophenyl)furan-2-yl]-5-[2-[5-[5-(2,4-dibromophenyl)furan-2-yl]-1,3,4-oxadiazol-2-yl]ethyl]-1,3,4-oxadiazole Chemical compound BrC1=CC(Br)=CC=C1C1=CC=C(C=2OC(CCC=3OC(=NN=3)C=3OC(=CC=3)C=3C(=CC(Br)=CC=3)Br)=NN=2)O1 JJDNUCCDEXEKEM-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 108010078321 Guanylate Cyclase Proteins 0.000 description 1
- 102000014469 Guanylate cyclase Human genes 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102000006541 Ionotropic Glutamate Receptors Human genes 0.000 description 1
- 108010008812 Ionotropic Glutamate Receptors Proteins 0.000 description 1
- 108090000543 Ligand-Gated Ion Channels Proteins 0.000 description 1
- 102000004086 Ligand-Gated Ion Channels Human genes 0.000 description 1
- 102100036834 Metabotropic glutamate receptor 1 Human genes 0.000 description 1
- 102000011420 Phospholipase D Human genes 0.000 description 1
- 108090000553 Phospholipase D Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 230000000971 hippocampal effect Effects 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000001057 ionotropic effect Effects 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 230000020796 long term synaptic depression Effects 0.000 description 1
- 230000027928 long-term synaptic potentiation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108010014719 metabotropic glutamate receptor type 1 Proteins 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000007472 neurodevelopment Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000016273 neuron death Effects 0.000 description 1
- 239000004090 neuroprotective agent Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000003957 neurotransmitter release Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 230000035778 pathophysiological process Effects 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000020341 sensory perception of pain Effects 0.000 description 1
- 230000003956 synaptic plasticity Effects 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 210000001103 thalamus Anatomy 0.000 description 1
- 230000004462 vestibulo-ocular reflex Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000031836 visual learning Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40204002P | 2002-08-09 | 2002-08-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200500886B true ZA200500886B (en) | 2006-07-26 |
Family
ID=31715777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200500886A ZA200500886B (en) | 2002-08-09 | 2005-01-31 | "1,2,4" Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
Country Status (20)
Country | Link |
---|---|
US (2) | US20040152699A1 (ko) |
EP (1) | EP1529045A2 (ko) |
JP (2) | JP4637578B2 (ko) |
KR (1) | KR20050033070A (ko) |
CN (2) | CN101723941A (ko) |
AR (1) | AR040847A1 (ko) |
AU (1) | AU2003259068B2 (ko) |
BR (1) | BR0313265A (ko) |
CA (1) | CA2494987C (ko) |
IL (1) | IL166510A0 (ko) |
IS (1) | IS7733A (ko) |
MX (1) | MXPA05001594A (ko) |
NO (1) | NO20051225L (ko) |
NZ (1) | NZ538225A (ko) |
PL (1) | PL375256A1 (ko) |
RU (1) | RU2352568C9 (ko) |
TW (1) | TWI341314B (ko) |
UA (1) | UA87653C2 (ko) |
WO (1) | WO2004014881A2 (ko) |
ZA (1) | ZA200500886B (ko) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101723941A (zh) * | 2002-08-09 | 2010-06-09 | 阿斯利康(瑞典)有限公司 | 作为代谢型谷氨酸受体-5调节剂的“1,2,4”二唑 |
KR101168441B1 (ko) | 2003-05-30 | 2012-07-25 | 게민 엑스 파마슈티컬스 캐나다 인코포레이티드 | 암 또는 바이러스 질환의 치료를 위한 삼복소환 화합물,조성물 및 방법 |
WO2005077345A1 (en) * | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Compounds for the treatment of gastro-esophageal reflux disease |
AU2005214380A1 (en) | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders |
EA200601266A1 (ru) * | 2004-02-18 | 2007-02-27 | Астразенека Аб | Соединения триазола и их применение в качестве антагонистов метаботропного рецептора глутамата |
US7585881B2 (en) * | 2004-02-18 | 2009-09-08 | Astrazeneca Ab | Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
US7855298B2 (en) * | 2004-02-23 | 2010-12-21 | Glaxo Group Limited | Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine D3 receptors |
US20050288347A1 (en) * | 2004-03-26 | 2005-12-29 | Hodge Carl N | Certain triazole-based compounds, compositions, and uses thereof |
KR101214665B1 (ko) | 2004-09-16 | 2012-12-21 | 아스텔라스세이야쿠 가부시키가이샤 | 트리아졸 유도체 또는 그의 염 |
JP4557685B2 (ja) | 2004-11-15 | 2010-10-06 | 独立行政法人理化学研究所 | 蛍光蛋白質 |
TW200635587A (en) * | 2004-12-01 | 2006-10-16 | Kalypsys Inc | Inducible nitric oxide synthase dimerization inhibitors |
ES2346685T3 (es) * | 2005-01-14 | 2010-10-19 | F. Hoffmann-La Roche Ag | Deribados de tiazol-4-carboxamida como antagonistas de mglur5. |
JPWO2006080533A1 (ja) * | 2005-01-31 | 2008-06-19 | 持田製薬株式会社 | 3−アミノ−1,2,4−トリアゾール誘導体 |
GB0510139D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B1 |
GB0510142D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds A1 |
PE20070427A1 (es) | 2005-08-30 | 2007-04-21 | Novartis Ag | Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas |
AR058807A1 (es) * | 2005-09-29 | 2008-02-27 | Astrazeneca Ab | 5-(fenilisoxazoletoxi)-triazol-3-il piridinas sustituidas, para el tratamiento de trastornos mediados por el receptor mglur5 |
CA2628146A1 (en) * | 2005-11-28 | 2007-05-31 | Kalypsys, Inc. | Salts of inducible nitric oxide synthase dimerization inhibitors |
TW200811157A (en) | 2006-05-05 | 2008-03-01 | Astrazeneca Ab | mGluR5 modulators I |
WO2008031550A2 (en) | 2006-09-11 | 2008-03-20 | Novartis Ag | Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
TW200821305A (en) * | 2006-10-05 | 2008-05-16 | Astrazeneca Ab | MGluR5 modulators |
BRPI0720043A2 (pt) * | 2006-12-15 | 2014-01-07 | Abbott Lab | Composto oxadiazol |
US20110207704A1 (en) * | 2006-12-15 | 2011-08-25 | Abbott Laboratories | Novel Oxadiazole Compounds |
EP1958631A1 (en) * | 2007-02-14 | 2008-08-20 | AEterna Zentaris GmbH | Novel triazole derivatives as ligands of G-protein coupled receptors |
AU2008277730B2 (en) | 2007-07-13 | 2013-01-31 | Addex Pharma S.A. | Pyrazole derivatives as modulators of metabotropic glutamate receptors |
EP2947080B1 (en) | 2007-08-13 | 2017-10-25 | Monsanto Technology LLC | Compositions and methods for controlling nematodes |
EP2211619A1 (en) * | 2007-10-18 | 2010-08-04 | Merck Sharp & Dohme Corp. | Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
CN101896480A (zh) * | 2007-10-19 | 2010-11-24 | 阿斯利康(瑞典)有限公司 | 作为亲代谢性谷氨酸受体(mglurs)调节剂的四唑衍生物 |
WO2009054785A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | 1,2,4-triazole ether derivatives as modulators of mglur5 |
BRPI0911808A2 (pt) * | 2008-04-28 | 2016-10-18 | Astrazeneca Ab | método para preparar um composto, e, composição |
EP2280959B1 (en) | 2008-06-05 | 2012-04-04 | Glaxo Group Limited | 4-amino-indazoles |
ES2445199T3 (es) | 2008-06-05 | 2014-02-28 | Glaxo Group Limited | Derivados de benzpirazol como inhibidores de PI3-quinasas |
WO2009147189A1 (en) | 2008-06-05 | 2009-12-10 | Glaxo Group Limited | Novel compounds |
EP2288607B1 (en) | 2008-06-09 | 2014-09-24 | Sanofi | Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
CA2729595C (en) | 2008-06-30 | 2017-01-03 | Novartis Ag | Combinations comprising mglur modulators for the treatment of parkinson's disease |
CN102076671B (zh) | 2008-07-03 | 2013-05-15 | 安斯泰来制药有限公司 | 三唑衍生物或其盐 |
DE102008057343A1 (de) | 2008-11-14 | 2010-05-20 | Bayer Schering Pharma Aktiengesellschaft | Heterocyclisch substituierte Aryl-Verbindungen und ihre Verwendung |
DE102009041241A1 (de) | 2009-09-11 | 2011-08-04 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Substituierte Aryl-Verbindungen und ihre Verwendung |
DE102008057344A1 (de) | 2008-11-14 | 2010-05-20 | Bayer Schering Pharma Aktiengesellschaft | Aminoalkyl-substituierte Aryl-Verbindungen und ihre Verwendung |
DE102008057364A1 (de) | 2008-11-14 | 2010-05-20 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Aryl-Verbindungen und ihre Verwendung |
DE102009041242A1 (de) | 2009-09-11 | 2011-12-15 | Bayer Schering Pharma Aktiengesellschaft | Heterocyclisch substituierte Aryl-Verbindungen und ihre Verwendung |
WO2010071558A1 (en) * | 2008-12-18 | 2010-06-24 | Astrazeneca Ab | New process for the preparation of 1- [5- (3-chloro-phenyl) - isooxazol-3-yl] -ethanone and (r) -1- [5- (3-chloro-phenyl) - isooxazol-3-yl] -ethanol |
JP5656880B2 (ja) | 2009-03-09 | 2015-01-21 | グラクソ グループ リミテッドGlaxo Group Limited | Pi3キナーゼの阻害剤としての4−オキサジアゾール−2−イル−インダゾール |
PL2899191T3 (pl) | 2009-04-30 | 2018-01-31 | Glaxo Group Ltd | Indazole podstawione oksazolem jako inhibitory kinazy PI3 |
EP2438052A1 (en) | 2009-06-05 | 2012-04-11 | Oslo University Hospital HF | Azole derivatives as wtn pathway inhibitors |
US20110144049A1 (en) * | 2009-10-21 | 2011-06-16 | Serebruany Victor L | Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke with Cyclopentyl-Triazolo-Pyrimidine or Derivative Thereof |
TWI481607B (zh) * | 2009-12-17 | 2015-04-21 | Lundbeck & Co As H | 作為pde10a酵素抑制劑的2-芳基咪唑衍生物 |
WO2011082010A1 (en) | 2009-12-29 | 2011-07-07 | Eli Lilly And Company | Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia |
JP6026284B2 (ja) * | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
WO2011133920A1 (en) | 2010-04-23 | 2011-10-27 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
MA34263B1 (fr) | 2010-04-30 | 2013-05-02 | Novartis Ag | Marqueurs de prédiction utiles dans traitement du syndrome de l'x fragile (fxs) |
WO2012006760A1 (en) * | 2010-07-14 | 2012-01-19 | Merck Sharp & Dohme Corp. | Tricyclic compounds as allosteric modulators of metabotropic glutamate receptors |
UA112418C2 (uk) | 2010-09-07 | 2016-09-12 | Астеллас Фарма Інк. | Терапевтичний болезаспокійливий засіб |
GB201018124D0 (en) | 2010-10-27 | 2010-12-08 | Glaxo Group Ltd | Polymorphs and salts |
US20130203735A1 (en) * | 2010-10-28 | 2013-08-08 | John T. Sisko | Caprolactam mglur5 receptor modulators |
CN103429583A (zh) | 2010-12-08 | 2013-12-04 | 奥斯陆大学医院公司 | 作为wnt信号通路抑制剂的三唑衍生物 |
US8759380B2 (en) | 2011-04-22 | 2014-06-24 | Cytokinetics, Inc. | Certain heterocycles, compositions thereof, and methods for their use |
EP2704573A4 (en) | 2011-05-03 | 2014-10-15 | Merck Sharp & Dohme | AMINOMETHYL biaryl BENZOTRIAZOL DERIVATIVES |
US8592423B2 (en) | 2011-06-21 | 2013-11-26 | Bristol-Myers Squibb Company | Inhibitors of PDE10 |
EP2545964A1 (en) | 2011-07-13 | 2013-01-16 | Phenex Pharmaceuticals AG | Novel FXR (NR1H4) binding and activity modulating compounds |
WO2013131981A1 (en) | 2012-03-08 | 2013-09-12 | Novartis Ag | Predictive markers useful in the diagnosis and treatment of fragile x syndrome (fxs) |
US8889854B2 (en) | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
US8729263B2 (en) | 2012-08-13 | 2014-05-20 | Novartis Ag | 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions |
CN104884452A (zh) | 2012-11-20 | 2015-09-02 | 沃泰克斯药物股份有限公司 | 用作吲哚胺2,3-二氧化酶的抑制剂的化合物 |
US9040712B2 (en) | 2013-01-23 | 2015-05-26 | Novartis Ag | Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions |
CN105636953B (zh) | 2013-07-31 | 2018-01-02 | 诺华股份有限公司 | 1,4‑二取代的哒嗪衍生物及其用于治疗与smn缺乏相关的病症的用途 |
JP6596090B2 (ja) | 2014-12-17 | 2019-10-23 | キングス カレッジ ロンドン | レチノイン酸受容体ベータ(RARβ)アゴニストとしてのビシクロヘテロアリール−ヘテロアリール−安息香酸化合物 |
GB201506658D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
GB201506660D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
EP3159332A1 (en) | 2015-10-23 | 2017-04-26 | Ludwig-Maximilians-Universität München | 5,5'-bis(2,4,6-trinitrophenyl)-2,2'-bi(1,3,4-oxadiazole) and bis(2,4,6-trinitrobenzoyl)oxalohydrazide |
CA2968836A1 (en) | 2016-06-13 | 2017-12-13 | Gilead Sciences, Inc. | Fxr (nr1h4) modulating compounds |
EP3730487B1 (en) | 2016-06-13 | 2022-04-27 | Gilead Sciences, Inc. | Azetidine derivatives as fxr (nr1h4) modulators |
GB201610867D0 (en) | 2016-06-22 | 2016-08-03 | King S College London | Crystalline forms of a therapeutic compound and processes for their preparation |
PT3600309T (pt) | 2017-03-28 | 2022-10-03 | Gilead Sciences Inc | Combinações terapêuticas para o tratamento de doenças hepáticas |
EP3682881A4 (en) * | 2017-09-14 | 2021-08-11 | Daiichi Sankyo Company, Limited | CONNECTION WITH CYCLICAL STRUCTURE |
CN111372576A (zh) | 2017-11-17 | 2020-07-03 | 塞尔利克斯生物私人有限公司 | 用于治疗眼部病症的组合物和方法 |
SI3911647T1 (sl) | 2019-01-15 | 2024-04-30 | Gilead Sciences, Inc. | Izoksazolna spojina kot agonist FXR in farmacevtski sestavki, ki jo obsegajo |
JP2022519906A (ja) | 2019-02-19 | 2022-03-25 | ギリアード サイエンシーズ, インコーポレイテッド | Fxrアゴニストの固体形態 |
EP3771711A1 (en) | 2019-07-29 | 2021-02-03 | Bayer Animal Health GmbH | Pyrazole derivatives for controlling arthropods |
CN111362934A (zh) * | 2020-04-21 | 2020-07-03 | 南开大学 | 一类异噻唑联噁二唑衍生物及其制备方法和用途 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3740434A (en) * | 1966-12-23 | 1973-06-19 | American Cyanamid Co | Substituted nitroimidazolylthiadiazoles and oxadiazoles as antiprotozoal agents |
US3816426A (en) * | 1970-10-27 | 1974-06-11 | Abbott Lab | 1-(5-phenyl-4-oxo-2-oxazolin-2-yl)piperazines |
JPS56127364A (en) | 1980-03-01 | 1981-10-06 | Mitsui Toatsu Chem Inc | Novel piperazine compound, its preparation and utilization |
JP3003148B2 (ja) | 1989-01-05 | 2000-01-24 | 藤沢薬品工業株式会社 | チアゾール化合物、その製造法およびそれを含有する医薬組成物 |
US5140034A (en) * | 1989-03-14 | 1992-08-18 | Merck Sharp & Dohme Ltd. | Five-membered ring systems with bonded imidazolyl ring substituents |
US4914207A (en) * | 1989-05-09 | 1990-04-03 | Pfizer Inc. | Arylthiazolylimidazoles |
DE3929673A1 (de) * | 1989-09-07 | 1991-03-14 | Bayer Ag | Substituierte carbamoyltriazole |
IL96891A0 (en) | 1990-01-17 | 1992-03-29 | Merck Sharp & Dohme | Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them |
AU678186B2 (en) * | 1992-10-23 | 1997-05-22 | Merck Sharp & Dohme Limited | Dopamine receptor subtype ligands |
DE19725450A1 (de) | 1997-06-16 | 1998-12-17 | Hoechst Schering Agrevo Gmbh | 4-Haloalkyl-3-heterocyclylpyridine und 4-Haloalkyl-5-heterocyclylpyrimidine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel |
DE19858193A1 (de) * | 1998-12-17 | 2000-06-21 | Aventis Cropscience Gmbh | 4-Trifluormethyl-3-oxadiazolylpyridine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel |
WO1999026927A2 (en) * | 1997-11-21 | 1999-06-03 | Nps Pharmaceuticals, Inc. | Metabotropic glutamate receptor antagonists for treating central nervous system diseases |
DE19858191A1 (de) | 1998-12-17 | 2000-06-21 | Aventis Cropscience Gmbh | 4-Haloalkyl-3-heterocyclylpyridine und 4-Haloalkyl-5-heterocyclyl-pyrimidine und ihre Verwendung als Repellentien |
DE19858192A1 (de) * | 1998-12-17 | 2000-06-21 | Aventis Cropscience Gmbh | 4-Trifluormethyl-3-oxazolylpyridine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel |
CO5170501A1 (es) | 1999-04-14 | 2002-06-27 | Novartis Ag | AZOLES SUSTITUIDOS UTILES PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR TNFa eIL-1 Y ENFERMEDADES DEL METABOLISMO OSEO |
AU780191B2 (en) | 1999-08-19 | 2005-03-03 | Astrazeneca Ab | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
AU7989400A (en) * | 1999-10-01 | 2001-05-10 | Smithkline Beecham Corporation | Compounds and methods |
TWI283577B (en) | 1999-10-11 | 2007-07-11 | Sod Conseils Rech Applic | Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof |
DE19962901A1 (de) | 1999-12-23 | 2001-07-05 | Aventis Cropscience Gmbh | Azolylalkalylazol-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel |
PL361397A1 (en) | 2000-09-21 | 2004-10-04 | Smithkline Beecham P.L.C. | Imidazole derivatives as raf kinase inhibitors |
AU2956702A (en) | 2000-12-04 | 2002-06-18 | Hoffmann La Roche | Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
DE60203623T2 (de) | 2001-07-19 | 2006-01-19 | CV Therapeutics, Inc., Palo Alto | Substituierte piperazinderivate und ihre verwendung als fettsaüre-oxidationsinhibitoren |
CN101723941A (zh) * | 2002-08-09 | 2010-06-09 | 阿斯利康(瑞典)有限公司 | 作为代谢型谷氨酸受体-5调节剂的“1,2,4”二唑 |
WO2005077345A1 (en) | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Compounds for the treatment of gastro-esophageal reflux disease |
PL1716152T3 (pl) | 2004-02-18 | 2009-01-30 | Astrazeneca Ab | Skondensowane związki heterocykliczne i ich zastosowanie jako antagonistów receptora metabotropowego do leczenia zaburzeń żołądkowo-jelitowych |
US7585881B2 (en) * | 2004-02-18 | 2009-09-08 | Astrazeneca Ab | Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
AR058807A1 (es) * | 2005-09-29 | 2008-02-27 | Astrazeneca Ab | 5-(fenilisoxazoletoxi)-triazol-3-il piridinas sustituidas, para el tratamiento de trastornos mediados por el receptor mglur5 |
-
2003
- 2003-08-08 CN CN200910208474A patent/CN101723941A/zh active Pending
- 2003-08-08 CN CNA038238454A patent/CN1894241A/zh active Pending
- 2003-08-08 CA CA2494987A patent/CA2494987C/en not_active Expired - Fee Related
- 2003-08-08 KR KR1020057002101A patent/KR20050033070A/ko not_active Application Discontinuation
- 2003-08-08 MX MXPA05001594A patent/MXPA05001594A/es active IP Right Grant
- 2003-08-08 RU RU2005106844/04A patent/RU2352568C9/ru not_active IP Right Cessation
- 2003-08-08 BR BR0313265-0A patent/BR0313265A/pt not_active Application Discontinuation
- 2003-08-08 PL PL03375256A patent/PL375256A1/xx unknown
- 2003-08-08 JP JP2004527872A patent/JP4637578B2/ja not_active Expired - Fee Related
- 2003-08-08 US US10/637,012 patent/US20040152699A1/en not_active Abandoned
- 2003-08-08 AU AU2003259068A patent/AU2003259068B2/en not_active Ceased
- 2003-08-08 UA UAA200501100A patent/UA87653C2/ru unknown
- 2003-08-08 WO PCT/US2003/024846 patent/WO2004014881A2/en active Application Filing
- 2003-08-08 EP EP03785036A patent/EP1529045A2/en not_active Withdrawn
- 2003-08-08 IL IL16651003A patent/IL166510A0/xx unknown
- 2003-08-08 NZ NZ538225A patent/NZ538225A/en not_active IP Right Cessation
- 2003-08-08 TW TW092121880A patent/TWI341314B/zh not_active IP Right Cessation
- 2003-08-08 AR AR20030102891A patent/AR040847A1/es unknown
-
2005
- 2005-01-31 ZA ZA200500886A patent/ZA200500886B/en unknown
- 2005-03-09 IS IS7733A patent/IS7733A/is unknown
- 2005-03-09 NO NO20051225A patent/NO20051225L/no unknown
- 2005-11-14 US US11/274,611 patent/US7456200B2/en not_active Expired - Fee Related
-
2010
- 2010-06-14 JP JP2010135508A patent/JP2010248214A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
TW200413361A (en) | 2004-08-01 |
CA2494987C (en) | 2012-04-17 |
AU2003259068A1 (en) | 2004-02-25 |
EP1529045A2 (en) | 2005-05-11 |
BR0313265A (pt) | 2005-07-05 |
AU2003259068B2 (en) | 2009-07-02 |
WO2004014881A3 (en) | 2004-05-27 |
JP2006503009A (ja) | 2006-01-26 |
US20060122397A1 (en) | 2006-06-08 |
JP2010248214A (ja) | 2010-11-04 |
AR040847A1 (es) | 2005-04-20 |
WO2004014881B1 (en) | 2004-07-15 |
TWI341314B (en) | 2011-05-01 |
WO2004014881A2 (en) | 2004-02-19 |
IS7733A (is) | 2005-03-09 |
MXPA05001594A (es) | 2005-09-20 |
RU2352568C2 (ru) | 2009-04-20 |
CA2494987A1 (en) | 2004-02-19 |
US7456200B2 (en) | 2008-11-25 |
PL375256A1 (en) | 2005-11-28 |
IL166510A0 (en) | 2006-01-15 |
CN1894241A (zh) | 2007-01-10 |
NZ538225A (en) | 2008-05-30 |
US20040152699A1 (en) | 2004-08-05 |
KR20050033070A (ko) | 2005-04-08 |
RU2352568C9 (ru) | 2009-06-27 |
NO20051225L (no) | 2005-05-09 |
RU2005106844A (ru) | 2005-08-27 |
UA87653C2 (en) | 2009-08-10 |
CN101723941A (zh) | 2010-06-09 |
JP4637578B2 (ja) | 2011-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200500886B (en) | "1,2,4" Oxadiazoles as modulators of metabotropic glutamate receptor-5 | |
JP2006503009A5 (ko) | ||
WO2005077345A1 (en) | Compounds for the treatment of gastro-esophageal reflux disease | |
AU2011207229B2 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
US9493446B2 (en) | Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives | |
ES2536191T3 (es) | Derivados de sulfonamida | |
TWI358409B (en) | Heteroaryl substituted piperidine derivatives | |
AP767A (en) | Quinoxalinediones | |
JP2020530446A5 (ko) | ||
US20110301143A1 (en) | Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase | |
NZ577004A (en) | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use | |
JP2012501975A (ja) | ステアロイルコエンザイムAδ−9デサチュラーゼの阻害剤としての芳香族複素環化合物 | |
TW201900175A (zh) | 作為pge2受體調節劑之苯基衍生物 | |
JP5602230B2 (ja) | スフィンゴシン−1−リン酸受容体アゴニスト | |
JP2019516737A5 (ko) | ||
US11820773B2 (en) | Tricyclic compounds | |
US20200385372A1 (en) | Combination treatments comprising administration of 1h-pyrazolo[4,3-b]pyridines | |
US20230069174A1 (en) | Nitrogen-containing heterocyclic autotaxin inhibitor, and composition containing same and use thereof | |
TW201825497A (zh) | 經n-環取代之噻吩并尿嘧啶類及其用途 | |
CN118715231A (zh) | 补体因子抑制剂及其用途 | |
KR20070018006A (ko) | 헤테로폴리시클릭 화합물 및 대사성 글루타메이트 수용체길항제로서 이들의 용도 |